Frequencies for first 10,000 rows of pt variable in reac2013q1 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL PAIN | 1 0.01 0.01 ABNORMAL BEHAVIOUR | 1 0.01 0.02 ABNORMAL DREAMS | 1 0.01 0.03 ACCELERATED IDIOVENTRICULAR RHYTHM | 1 0.01 0.04 ALANINE AMINOTRANSFERASE INCREASED | 1 0.01 0.05 ANAEMIA | 1 0.01 0.06 ANAL FISSURE | 1 0.01 0.07 ANGER | 1 0.01 0.08 ANGLE CLOSURE GLAUCOMA | 1 0.01 0.09 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE | 1 0.01 0.10 ANXIETY | 1 0.01 0.11 AORTIC DISSECTION RUPTURE | 1 0.01 0.12 APLASIA PURE RED CELL | 2 0.02 0.14 APPARENT LIFE THREATENING EVENT | 1 0.01 0.15 ASPIRATION | 1 0.01 0.16 ATRIOVENTRICULAR BLOCK | 1 0.01 0.17 ATRIOVENTRICULAR DISSOCIATION | 1 0.01 0.18 Abasia | 14 0.14 0.32 Abdominal abscess | 2 0.02 0.34 Abdominal adhesions | 1 0.01 0.35 Abdominal discomfort | 14 0.14 0.49 Abdominal distension | 7 0.07 0.56 Abdominal hernia | 2 0.02 0.58 Abdominal infection | 1 0.01 0.59 Abdominal pain | 29 0.29 0.88 Abdominal pain lower | 1 0.01 0.89 Abdominal pain upper | 19 0.19 1.08 Abdominal wall abscess | 1 0.01 1.09 Abdominoplasty | 1 0.01 1.10 Abnormal behaviour | 8 0.08 1.18 Abnormal dreams | 6 0.06 1.24 Abnormal loss of weight | 1 0.01 1.25 Abnormal weight gain | 1 0.01 1.26 Abortion | 1 0.01 1.27 Abortion induced | 5 0.05 1.32 Abortion spontaneous | 19 0.19 1.51 Abscess | 4 0.04 1.55 Abscess jaw | 1 0.01 1.56 Abscess limb | 1 0.01 1.57 Abulia | 2 0.02 1.59 Acalculia | 1 0.01 1.60 Acanthosis | 2 0.02 1.62 Accident | 6 0.06 1.68 Accidental exposure to product | 2 0.02 1.70 Accidental exposure to product by child | 3 0.03 1.73 Accidental overdose | 2 0.02 1.75 Acidosis | 1 0.01 1.76 Acne | 6 0.06 1.82 Acquired claw toe | 1 0.01 1.83 Acquired epidermolysis bullosa | 1 0.01 1.84 Acrochordon | 1 0.01 1.85 Actinic keratosis | 1 0.01 1.86 Actinomycosis | 1 0.01 1.87 Activities of daily living impaired | 11 0.11 1.98 Acute abdomen | 1 0.01 1.99 Acute coronary syndrome | 1 0.01 2.00 Acute febrile neutrophilic dermatosis | 1 0.01 2.01 Acute graft versus host disease in in.. | 1 0.01 2.02 Acute graft versus host disease in li.. | 1 0.01 2.03 Acute graft versus host disease in skin | 1 0.01 2.04 Acute hepatic failure | 4 0.04 2.08 Acute hepatitis B | 2 0.02 2.10 Acute myeloid leukaemia | 5 0.05 2.15 Acute myocardial infarction | 7 0.07 2.22 Acute prerenal failure | 1 0.01 2.23 Acute psychosis | 1 0.01 2.24 Acute pulmonary oedema | 3 0.03 2.27 Acute respiratory distress syndrome | 4 0.04 2.31 Acute respiratory failure | 3 0.03 2.34 Acute sinusitis | 1 0.01 2.35 Adenocarcinoma of colon | 1 0.01 2.36 Adnexa uteri pain | 1 0.01 2.37 Adrenal atrophy | 1 0.01 2.38 Adrenal cortex necrosis | 1 0.01 2.39 Adrenal haemorrhage | 1 0.01 2.40 Adrenal insufficiency | 3 0.03 2.43 Adrenalitis | 1 0.01 2.44 Adverse drug reaction | 3 0.03 2.47 Adverse event | 9 0.09 2.56 Affective disorder | 3 0.03 2.59 Ageusia | 3 0.03 2.62 Aggression | 9 0.09 2.71 Agitation | 11 0.11 2.82 Agranulocytosis | 4 0.04 2.86 Agraphia | 1 0.01 2.87 Akathisia | 5 0.05 2.92 Alanine aminotransferase abnormal | 1 0.01 2.93 Alanine aminotransferase increased | 22 0.22 3.15 Albinism | 1 0.01 3.16 Alcohol interaction | 1 0.01 3.17 Alcohol poisoning | 1 0.01 3.18 Alcohol use | 2 0.02 3.20 Alcohol withdrawal syndrome | 1 0.01 3.21 Alcoholic pancreatitis | 1 0.01 3.22 Alcoholism | 1 0.01 3.23 Allergy to animal | 1 0.01 3.24 Alopecia | 14 0.14 3.38 Alpha 1 foetoprotein increased | 1 0.01 3.39 Altered state of consciousness | 9 0.09 3.48 Alveolitis allergic | 1 0.01 3.49 Amenorrhoea | 3 0.03 3.52 Amino acid level increased | 1 0.01 3.53 Amnesia | 20 0.20 3.73 Amniorrhoea | 1 0.01 3.74 Amniotic cavity infection | 1 0.01 3.75 Amniotic fluid volume decreased | 2 0.02 3.77 Amniotic fluid volume increased | 1 0.01 3.78 Amniotic infection syndrome of Blane | 1 0.01 3.79 Amylase increased | 1 0.01 3.80 Amyloidosis | 1 0.01 3.81 Anaemia | 36 0.36 4.17 Anaemia megaloblastic | 1 0.01 4.18 Anaemia of chronic disease | 1 0.01 4.19 Anaemia postoperative | 1 0.01 4.20 Anaemia vitamin B12 deficiency | 1 0.01 4.21 Anal abscess | 3 0.03 4.24 Anal cancer | 1 0.01 4.25 Anal fissure | 3 0.03 4.28 Anal fistula | 4 0.04 4.32 Anal inflammation | 1 0.01 4.33 Anal pruritus | 1 0.01 4.34 Analgesic drug level increased | 1 0.01 4.35 Anaphylactic reaction | 6 0.06 4.41 Anaphylactic shock | 2 0.02 4.43 Anaphylactoid reaction | 1 0.01 4.44 Anger | 3 0.03 4.47 Angina pectoris | 4 0.04 4.51 Angina unstable | 3 0.03 4.54 Angioedema | 2 0.02 4.56 Angiopathy | 2 0.02 4.58 Angiotensin converting enzyme increased | 1 0.01 4.59 Anhedonia | 6 0.06 4.65 Ankle fracture | 10 0.10 4.75 Ankylosing spondylitis | 1 0.01 4.76 Anorgasmia | 1 0.01 4.77 Anosmia | 1 0.01 4.78 Anti-insulin antibody increased | 2 0.02 4.80 Anti-insulin antibody positive | 2 0.02 4.82 Antibody test positive | 1 0.01 4.83 Anticonvulsant drug level above thera.. | 1 0.01 4.84 Anticonvulsant drug level decreased | 1 0.01 4.85 Anticonvulsant drug level increased | 1 0.01 4.86 Antiphospholipid antibodies positive | 2 0.02 4.88 Antipsychotic drug level above therap.. | 1 0.01 4.89 Antiviral drug level below therapeutic | 1 0.01 4.90 Anuria | 4 0.04 4.94 Anxiety | 67 0.67 5.61 Anxiety disorder | 2 0.02 5.63 Aorta hypoplasia | 1 0.01 5.64 Aortic aneurysm | 1 0.01 5.65 Aortic aneurysm rupture | 2 0.02 5.67 Aortic rupture | 1 0.01 5.68 Aortic stenosis | 2 0.02 5.70 Aortic valve incompetence | 2 0.02 5.72 Aortic valve sclerosis | 1 0.01 5.73 Aorto-duodenal fistula | 1 0.01 5.74 Apathy | 4 0.04 5.78 Apgar score abnormal | 1 0.01 5.79 Aphagia | 8 0.08 5.87 Aphasia | 12 0.12 5.99 Aphonia | 1 0.01 6.00 Aphthous stomatitis | 1 0.01 6.01 Aplastic anaemia | 2 0.02 6.03 Apnoea | 5 0.05 6.08 Apnoea neonatal | 1 0.01 6.09 Apparent death | 1 0.01 6.10 Appendicectomy | 1 0.01 6.11 Appendicitis | 4 0.04 6.15 Appendicitis perforated | 1 0.01 6.16 Appendix disorder | 1 0.01 6.17 Appetite disorder | 2 0.02 6.19 Application site hypersensitivity | 1 0.01 6.20 Apraxia | 1 0.01 6.21 Aptyalism | 1 0.01 6.22 Arachnoiditis | 1 0.01 6.23 Arrhythmia | 7 0.07 6.30 Arterial disorder | 1 0.01 6.31 Arterial occlusive disease | 1 0.01 6.32 Arterial thrombosis | 1 0.01 6.33 Arteriosclerosis | 1 0.01 6.34 Arteriosclerosis coronary artery | 3 0.03 6.37 Arteriovenous malformation | 1 0.01 6.38 Arthralgia | 55 0.55 6.93 Arthritis | 18 0.18 7.11 Arthritis infective | 2 0.02 7.13 Arthropathy | 9 0.09 7.22 Arthropod bite | 1 0.01 7.23 Ascites | 5 0.05 7.28 Aspartate aminotransferase abnormal | 1 0.01 7.29 Aspartate aminotransferase increased | 16 0.16 7.45 Asperger's disorder | 1 0.01 7.46 Aspergillus infection | 1 0.01 7.47 Asphyxia | 1 0.01 7.48 Aspiration | 2 0.02 7.50 Asteatosis | 1 0.01 7.51 Asthenia | 73 0.73 8.24 Asthma | 13 0.13 8.37 Ataxia | 5 0.05 8.42 Atelectasis | 5 0.05 8.47 Atonic urinary bladder | 1 0.01 8.48 Atrial conduction time prolongation | 2 0.02 8.50 Atrial fibrillation | 13 0.13 8.63 Atrial flutter | 1 0.01 8.64 Atrial septal defect | 3 0.03 8.67 Atrioventricular block | 3 0.03 8.70 Atrioventricular block complete | 2 0.02 8.72 Atrioventricular block first degree | 1 0.01 8.73 Atrophic glossitis | 1 0.01 8.74 Atrophy | 2 0.02 8.76 Attention deficit/hyperactivity disor.. | 2 0.02 8.78 Atypical pneumonia | 2 0.02 8.80 Autoimmune hepatitis | 2 0.02 8.82 Autoimmune thyroiditis | 2 0.02 8.84 Autonomic nervous system imbalance | 2 0.02 8.86 Axillary mass | 1 0.01 8.87 Azotaemia | 1 0.01 8.88 BASAL CELL CARCINOMA | 1 0.01 8.89 BK virus infection | 1 0.01 8.90 BLINDNESS | 1 0.01 8.91 BLOOD ALCOHOL INCREASED | 1 0.01 8.92 BLOOD ALKALINE PHOSPHATASE INCREASED | 1 0.01 8.93 BLOOD BILIRUBIN INCREASED | 1 0.01 8.94 BLOOD CREATINE PHOSPHOKINASE INCREASED | 2 0.02 8.96 BLOOD CREATINE PHOSPHOKINASE MB INCRE.. | 1 0.01 8.97 BLOOD CREATININE INCREASED | 2 0.02 8.99 BLOOD POTASSIUM DECREASED | 1 0.01 9.00 BLOOD PROLACTIN INCREASED | 1 0.01 9.01 BLOOD TEST ABNORMAL | 1 0.01 9.02 BLOOD UREA INCREASED | 1 0.01 9.03 BRADYKINESIA | 1 0.01 9.04 BREATH SOUNDS ABNORMAL | 1 0.01 9.05 BRUXISM | 2 0.02 9.07 Babesiosis | 1 0.01 9.08 Back disorder | 4 0.04 9.12 Back injury | 3 0.03 9.15 Back pain | 38 0.38 9.53 Bacteraemia | 1 0.01 9.54 Bacterial infection | 7 0.07 9.61 Bacterial sepsis | 1 0.01 9.62 Balance disorder | 28 0.28 9.90 Barrett's oesophagus | 3 0.03 9.93 Basal cell carcinoma | 3 0.03 9.96 Bedridden | 1 0.01 9.97 Benign hepatic neoplasm | 2 0.02 9.99 Benign intracranial hypertension | 1 0.01 10.00 Benign neoplasm of adrenal gland | 1 0.01 10.01 Benign prostatic hyperplasia | 1 0.01 10.02 Benign renal neoplasm | 1 0.01 10.03 Beta haemolytic streptococcal infection | 1 0.01 10.04 Bicuspid aortic valve | 1 0.01 10.05 Biliary dilatation | 1 0.01 10.06 Biliary dyskinesia | 1 0.01 10.07 Bilirubin conjugated increased | 3 0.03 10.10 Binocular eye movement disorder | 1 0.01 10.11 Biopsy liver | 1 0.01 10.12 Biopsy skin abnormal | 1 0.01 10.13 Bipolar I disorder | 1 0.01 10.14 Bipolar disorder | 4 0.04 10.18 Bite | 2 0.02 10.20 Bladder cancer | 4 0.04 10.24 Bladder disorder | 3 0.03 10.27 Bladder dysfunction | 1 0.01 10.28 Bladder neck suspension | 1 0.01 10.29 Bladder prolapse | 1 0.01 10.30 Bladder transitional cell carcinoma | 2 0.02 10.32 Bleeding time prolonged | 2 0.02 10.34 Bleeding varicose vein | 1 0.01 10.35 Blepharospasm | 1 0.01 10.36 Blighted ovum | 1 0.01 10.37 Blindness | 8 0.08 10.45 Blindness transient | 1 0.01 10.46 Blindness unilateral | 3 0.03 10.49 Blister | 6 0.06 10.55 Blood albumin decreased | 1 0.01 10.56 Blood alkaline phosphatase abnormal | 1 0.01 10.57 Blood alkaline phosphatase increased | 10 0.10 10.67 Blood bicarbonate decreased | 1 0.01 10.68 Blood bilirubin increased | 4 0.04 10.72 Blood calcium decreased | 2 0.02 10.74 Blood calcium increased | 2 0.02 10.76 Blood chloride decreased | 1 0.01 10.77 Blood cholesterol abnormal | 3 0.03 10.80 Blood cholesterol increased | 18 0.18 10.98 Blood count abnormal | 1 0.01 10.99 Blood creatine increased | 2 0.02 11.01 Blood creatine phosphokinase MB incre.. | 1 0.01 11.02 Blood creatine phosphokinase decreased | 1 0.01 11.03 Blood creatine phosphokinase increased | 12 0.12 11.15 Blood creatinine abnormal | 1 0.01 11.16 Blood creatinine increased | 13 0.13 11.29 Blood electrolytes increased | 1 0.01 11.30 Blood glucose abnormal | 1 0.01 11.31 Blood glucose decreased | 4 0.04 11.35 Blood glucose increased | 19 0.19 11.54 Blood homocysteine increased | 1 0.01 11.55 Blood iron decreased | 3 0.03 11.58 Blood lactate dehydrogenase decreased | 1 0.01 11.59 Blood lactate dehydrogenase increased | 8 0.08 11.67 Blood lactic acid increased | 1 0.01 11.68 Blood magnesium decreased | 2 0.02 11.70 Blood oestrogen decreased | 1 0.01 11.71 Blood osmolarity increased | 1 0.01 11.72 Blood potassium abnormal | 1 0.01 11.73 Blood potassium decreased | 5 0.05 11.78 Blood potassium increased | 4 0.04 11.82 Blood pressure decreased | 6 0.06 11.88 Blood pressure fluctuation | 7 0.07 11.95 Blood pressure increased | 23 0.23 12.18 Blood pressure management | 1 0.01 12.19 Blood pressure systolic decreased | 1 0.01 12.20 Blood pressure systolic increased | 3 0.03 12.23 Blood prolactin increased | 1 0.01 12.24 Blood sodium decreased | 4 0.04 12.28 Blood sodium increased | 1 0.01 12.29 Blood test abnormal | 3 0.03 12.32 Blood testosterone decreased | 2 0.02 12.34 Blood thyroid stimulating hormone dec.. | 4 0.04 12.38 Blood thyroid stimulating hormone inc.. | 1 0.01 12.39 Blood triglycerides increased | 5 0.05 12.44 Blood urea decreased | 1 0.01 12.45 Blood urea increased | 7 0.07 12.52 Blood uric acid increased | 4 0.04 12.56 Blood urine present | 1 0.01 12.57 Body height decreased | 2 0.02 12.59 Body temperature decreased | 1 0.01 12.60 Body temperature increased | 4 0.04 12.64 Bone cancer | 1 0.01 12.65 Bone contusion | 2 0.02 12.67 Bone cyst | 1 0.01 12.68 Bone density decreased | 3 0.03 12.71 Bone disorder | 4 0.04 12.75 Bone erosion | 1 0.01 12.76 Bone fragmentation | 1 0.01 12.77 Bone lesion | 3 0.03 12.80 Bone loss | 1 0.01 12.81 Bone marrow failure | 6 0.06 12.87 Bone marrow transplant | 1 0.01 12.88 Bone pain | 7 0.07 12.95 Bradycardia | 5 0.05 13.00 Bradykinesia | 2 0.02 13.02 Brain herniation | 2 0.02 13.04 Brain injury | 3 0.03 13.07 Brain neoplasm | 1 0.01 13.08 Brain neoplasm benign | 1 0.01 13.09 Brain oedema | 1 0.01 13.10 Brain stem infarction | 1 0.01 13.11 Breast cancer | 7 0.07 13.18 Breast cancer female | 11 0.11 13.29 Breast cancer male | 1 0.01 13.30 Breast cancer metastatic | 1 0.01 13.31 Breast cancer recurrent | 1 0.01 13.32 Breast cancer stage I | 4 0.04 13.36 Breast enlargement | 1 0.01 13.37 Breast lump removal | 1 0.01 13.38 Breast mass | 2 0.02 13.40 Breast necrosis | 1 0.01 13.41 Breast neoplasm | 1 0.01 13.42 Breast pain | 2 0.02 13.44 Breast reconstruction | 1 0.01 13.45 Breast tenderness | 1 0.01 13.46 Breath alcohol test positive | 1 0.01 13.47 Breath odour | 2 0.02 13.49 Breath sounds abnormal | 1 0.01 13.50 Bronchial fistula | 1 0.01 13.51 Bronchial neoplasm | 1 0.01 13.52 Bronchial obstruction | 1 0.01 13.53 Bronchial secretion retention | 2 0.02 13.55 Bronchiectasis | 1 0.01 13.56 Bronchitis | 24 0.24 13.80 Bronchitis chronic | 2 0.02 13.82 Bronchopneumonia | 2 0.02 13.84 Bruxism | 3 0.03 13.87 Bundle branch block left | 2 0.02 13.89 Bundle branch block right | 2 0.02 13.91 Burning sensation | 9 0.09 14.00 Burnout syndrome | 1 0.01 14.01 Bursitis | 5 0.05 14.06 C-reactive protein increased | 10 0.10 14.16 CARDIOACTIVE DRUG LEVEL INCREASED | 1 0.01 14.17 CD4 lymphocytes increased | 1 0.01 14.18 CHOROIDAL EFFUSION | 1 0.01 14.19 CHRONIC MYELOID LEUKAEMIA | 1 0.01 14.20 CLONUS | 1 0.01 14.21 COGNITIVE DISORDER | 1 0.01 14.22 COMA | 1 0.01 14.23 COMPLEX PARTIAL SEIZURES | 1 0.01 14.24 CONDITION AGGRAVATED | 3 0.03 14.27 CONVULSION | 1 0.01 14.28 CORNEAL OEDEMA | 1 0.01 14.29 CSF volume increased | 1 0.01 14.30 CYSTITIS | 1 0.01 14.31 CYTOMEGALOVIRUS TEST POSITIVE | 1 0.01 14.32 Cachexia | 1 0.01 14.33 Caesarean section | 1 0.01 14.34 Calcium deficiency | 1 0.01 14.35 Calculus urinary | 1 0.01 14.36 Campylobacter gastroenteritis | 1 0.01 14.37 Candida infection | 1 0.01 14.38 Carbuncle | 1 0.01 14.39 Cardiac ablation | 1 0.01 14.40 Cardiac arrest | 12 0.12 14.52 Cardiac disorder | 10 0.10 14.62 Cardiac failure | 13 0.13 14.75 Cardiac failure acute | 1 0.01 14.76 Cardiac failure congestive | 10 0.10 14.86 Cardiac fibrillation | 1 0.01 14.87 Cardiac flutter | 1 0.01 14.88 Cardiac hypertrophy | 1 0.01 14.89 Cardiac murmur | 4 0.04 14.93 Cardiac septal defect | 2 0.02 14.95 Cardiac tamponade | 2 0.02 14.97 Cardiac valve disease | 2 0.02 14.99 Cardiac valve vegetation | 1 0.01 15.00 Cardio-respiratory arrest | 4 0.04 15.04 Cardiogenic shock | 3 0.03 15.07 Cardiomegaly | 6 0.06 15.13 Cardiomyopathy | 3 0.03 15.16 Cardiopulmonary failure | 1 0.01 15.17 Cardiotoxicity | 1 0.01 15.18 Cardiovascular disorder | 2 0.02 15.20 Cardiovascular insufficiency | 2 0.02 15.22 Carotid arteriosclerosis | 1 0.01 15.23 Carotid artery dissection | 1 0.01 15.24 Carotid artery occlusion | 1 0.01 15.25 Carpal tunnel syndrome | 5 0.05 15.30 Cataract | 15 0.15 15.45 Catatonia | 2 0.02 15.47 Catheter site haemorrhage | 1 0.01 15.48 Catheter site swelling | 1 0.01 15.49 Catheterisation cardiac | 1 0.01 15.50 Cauda equina syndrome | 1 0.01 15.51 Cellulitis | 17 0.17 15.68 Cellulitis orbital | 1 0.01 15.69 Central nervous system inflammation | 1 0.01 15.70 Central nervous system lesion | 6 0.06 15.76 Central venous catheterisation | 1 0.01 15.77 Cephalhaematoma | 1 0.01 15.78 Cerebral atrophy | 3 0.03 15.81 Cerebral haemorrhage | 12 0.12 15.93 Cerebral hypoperfusion | 1 0.01 15.94 Cerebral infarction | 7 0.07 16.01 Cerebral microangiopathy | 1 0.01 16.02 Cerebral small vessel ischaemic disease | 2 0.02 16.04 Cerebral thrombosis | 5 0.05 16.09 Cerebral ventricle dilatation | 1 0.01 16.10 Cerebrovascular accident | 31 0.31 16.41 Cerebrovascular disorder | 1 0.01 16.42 Cervical dysplasia | 2 0.02 16.44 Cervical radiculopathy | 1 0.01 16.45 Cervical spinal stenosis | 1 0.01 16.46 Cervical vertebral fracture | 2 0.02 16.48 Cervicitis human papilloma virus | 1 0.01 16.49 Cervix carcinoma | 1 0.01 16.50 Cervix disorder | 1 0.01 16.51 Change of bowel habit | 1 0.01 16.52 Chapped lips | 1 0.01 16.53 Cheilitis | 3 0.03 16.56 Chest X-ray abnormal | 2 0.02 16.58 Chest discomfort | 12 0.12 16.70 Chest injury | 1 0.01 16.71 Chest pain | 33 0.33 17.04 Chest wall mass | 1 0.01 17.05 Chills | 14 0.14 17.19 Choking | 2 0.02 17.21 Cholangiocarcinoma | 1 0.01 17.22 Cholangitis acute | 1 0.01 17.23 Cholecystectomy | 6 0.06 17.29 Cholecystitis | 1 0.01 17.30 Cholecystitis chronic | 7 0.07 17.37 Cholelithiasis | 8 0.08 17.45 Cholestasis | 5 0.05 17.50 Chondrocalcinosis pyrophosphate | 1 0.01 17.51 Chondropathy | 4 0.04 17.55 Chromaturia | 4 0.04 17.59 Chronic actinic dermatitis | 1 0.01 17.60 Chronic fatigue syndrome | 1 0.01 17.61 Chronic graft versus host disease | 1 0.01 17.62 Chronic lymphocytic leukaemia | 1 0.01 17.63 Chronic myeloid leukaemia | 1 0.01 17.64 Chronic obstructive pulmonary disease | 9 0.09 17.73 Chronic sinusitis | 1 0.01 17.74 Circulatory collapse | 2 0.02 17.76 Circumstance or information capable o.. | 1 0.01 17.77 Clostridium difficile colitis | 3 0.03 17.80 Clostridium difficile infection | 2 0.02 17.82 Clostridium difficile sepsis | 1 0.01 17.83 Clumsiness | 1 0.01 17.84 Coagulation factor deficiency | 1 0.01 17.85 Coagulopathy | 2 0.02 17.87 Coarctation of the aorta | 2 0.02 17.89 Coeliac disease | 2 0.02 17.91 Cognitive disorder | 22 0.22 18.13 Cogwheel rigidity | 1 0.01 18.14 Cold sweat | 2 0.02 18.16 Colitis | 6 0.06 18.22 Colitis ischaemic | 3 0.03 18.25 Colitis microscopic | 1 0.01 18.26 Colitis ulcerative | 13 0.13 18.39 Colon adenoma | 1 0.01 18.40 Colon cancer | 4 0.04 18.44 Colon cancer metastatic | 4 0.04 18.48 Colon neoplasm | 2 0.02 18.50 Colonic abscess | 1 0.01 18.51 Colorectal cancer | 1 0.01 18.52 Colorectal cancer metastatic | 1 0.01 18.53 Coma | 11 0.11 18.64 Coma hepatic | 1 0.01 18.65 Coma scale abnormal | 2 0.02 18.67 Communication disorder | 1 0.01 18.68 Completed suicide | 15 0.15 18.83 Complex partial seizures | 1 0.01 18.84 Complex regional pain syndrome | 1 0.01 18.85 Complications of transplanted kidney | 3 0.03 18.88 Compression fracture | 1 0.01 18.89 Compulsive shopping | 2 0.02 18.91 Computerised tomogram head | 1 0.01 18.92 Concomitant disease aggravated | 1 0.01 18.93 Concomitant disease progression | 3 0.03 18.96 Concussion | 4 0.04 19.00 Condition aggravated | 26 0.26 19.26 Confusional state | 23 0.23 19.49 Congenital anomaly | 5 0.05 19.54 Congenital cystic kidney disease | 1 0.01 19.55 Congenital genital malformation | 1 0.01 19.56 Conjunctival disorder | 1 0.01 19.57 Conjunctival haemorrhage | 4 0.04 19.61 Conjunctivitis | 4 0.04 19.65 Conjunctivitis allergic | 1 0.01 19.66 Conjunctivitis infective | 2 0.02 19.68 Connective tissue disorder | 1 0.01 19.69 Constipation | 26 0.26 19.95 Contusion | 9 0.09 20.04 Conversion disorder | 1 0.01 20.05 Convulsion | 39 0.39 20.44 Convulsion neonatal | 2 0.02 20.46 Coordination abnormal | 7 0.07 20.53 Coproporphyrinogen increased | 1 0.01 20.54 Cor pulmonale | 1 0.01 20.55 Corneal degeneration | 1 0.01 20.56 Coronary artery disease | 2 0.02 20.58 Coronary artery occlusion | 6 0.06 20.64 Coronary artery restenosis | 1 0.01 20.65 Coronary artery stenosis | 2 0.02 20.67 Corynebacterium infection | 1 0.01 20.68 Costochondritis | 4 0.04 20.72 Cough | 38 0.38 21.10 Counterfeit drug administered | 1 0.01 21.11 Craniocerebral injury | 3 0.03 21.14 Creatinine renal clearance increased | 1 0.01 21.15 Crepitations | 1 0.01 21.16 Crohn's disease | 22 0.22 21.38 Crying | 9 0.09 21.47 Cryptococcosis | 1 0.01 21.48 Culture urine positive | 1 0.01 21.49 Culture wound positive | 1 0.01 21.50 Cutaneous lupus erythematosus | 5 0.05 21.55 Cutaneous vasculitis | 1 0.01 21.56 Cyanosis | 4 0.04 21.60 Cyanosis neonatal | 1 0.01 21.61 Cyst | 4 0.04 21.65 Cystitis | 10 0.10 21.75 Cystoscopy | 1 0.01 21.76 Cytomegalovirus chorioretinitis | 2 0.02 21.78 Cytomegalovirus hepatitis | 1 0.01 21.79 Cytomegalovirus infection | 5 0.05 21.84 Cytomegalovirus test positive | 2 0.02 21.86 DEHYDRATION | 2 0.02 21.88 DEMENTIA | 1 0.01 21.89 DEPRESSION | 2 0.02 21.91 DERMATITIS | 1 0.01 21.92 DERMATITIS EXFOLIATIVE | 1 0.01 21.93 DEVICE EXPULSION | 1 0.01 21.94 DIARRHOEA | 1 0.01 21.95 DILATATION INTRAHEPATIC DUCT ACQUIRED | 1 0.01 21.96 DISORIENTATION | 1 0.01 21.97 DISSOCIATION | 1 0.01 21.98 DISTURBANCE IN ATTENTION | 1 0.01 21.99 DIZZINESS | 1 0.01 22.00 DRUG ERUPTION | 1 0.01 22.01 DRUG HYPERSENSITIVITY | 3 0.03 22.04 DRUG INEFFECTIVE | 2 0.02 22.06 DRUG INTERACTION | 7 0.07 22.13 DRUG LEVEL DECREASED | 1 0.01 22.14 DRUG LEVEL INCREASED | 1 0.01 22.15 DRUG WITHDRAWAL SYNDROME | 1 0.01 22.16 DYSARTHRIA | 1 0.01 22.17 DYSPHAGIA | 1 0.01 22.18 DYSPNOEA | 1 0.01 22.19 DYSTONIA | 1 0.01 22.20 DYSURIA | 1 0.01 22.21 Dacryostenosis congenital | 1 0.01 22.22 Deafness | 8 0.08 22.30 Deafness bilateral | 1 0.01 22.31 Deafness neurosensory | 1 0.01 22.32 Deafness unilateral | 1 0.01 22.33 Death | 28 0.28 22.61 Debridement | 1 0.01 22.62 Decreased appetite | 24 0.24 22.86 Decreased immune responsiveness | 3 0.03 22.89 Decreased interest | 2 0.02 22.91 Decubitus ulcer | 1 0.01 22.92 Deep vein thrombosis | 38 0.38 23.30 Defaecation urgency | 2 0.02 23.32 Deformity | 5 0.05 23.37 Dehydration | 16 0.16 23.53 Delayed effects of radiation | 1 0.01 23.54 Delayed recovery from anaesthesia | 1 0.01 23.55 Delirium | 12 0.12 23.67 Delusion | 3 0.03 23.70 Delusional disorder, unspecified type | 1 0.01 23.71 Dementia | 5 0.05 23.76 Demyelinating polyneuropathy | 1 0.01 23.77 Demyelination | 3 0.03 23.80 Denervation atrophy | 1 0.01 23.81 Dental caries | 6 0.06 23.87 Dental necrosis | 1 0.01 23.88 Dependence | 3 0.03 23.91 Depersonalisation | 1 0.01 23.92 Depressed level of consciousness | 9 0.09 24.01 Depressed mood | 13 0.13 24.14 Depression | 77 0.77 24.91 Depressive symptom | 3 0.03 24.94 Dermatitis | 7 0.07 25.01 Dermatitis acneiform | 1 0.01 25.02 Dermatitis allergic | 4 0.04 25.06 Dermatitis bullous | 2 0.02 25.08 Dermatitis contact | 1 0.01 25.09 Dermatitis exfoliative | 5 0.05 25.14 Dermatomyositis | 1 0.01 25.15 Developmental delay | 1 0.01 25.16 Developmental hip dysplasia | 1 0.01 25.17 Device expulsion | 1 0.01 25.18 Device failure | 4 0.04 25.22 Device malfunction | 11 0.11 25.33 Device misuse | 1 0.01 25.34 Device related infection | 5 0.05 25.39 Device related sepsis | 2 0.02 25.41 Diabetes insipidus | 2 0.02 25.43 Diabetes mellitus | 19 0.19 25.62 Diabetes mellitus inadequate control | 7 0.07 25.69 Diabetic coma | 1 0.01 25.70 Diabetic ketoacidosis | 3 0.03 25.73 Diabetic retinopathy | 1 0.01 25.74 Dialysis | 3 0.03 25.77 Diaphragmatic hernia | 4 0.04 25.81 Diarrhoea | 56 0.56 26.37 Diastolic dysfunction | 2 0.02 26.39 Differential white blood cell count a.. | 1 0.01 26.40 Diffuse alveolar damage | 1 0.01 26.41 Dilatation intrahepatic duct acquired | 1 0.01 26.42 Dilatation ventricular | 1 0.01 26.43 Diplopia | 5 0.05 26.48 Disability | 5 0.05 26.53 Discomfort | 2 0.02 26.55 Disease progression | 10 0.10 26.65 Disease recurrence | 1 0.01 26.66 Disinhibition | 1 0.01 26.67 Disorientation | 5 0.05 26.72 Disseminated cytomegaloviral infection | 1 0.01 26.73 Disseminated intravascular coagulation | 2 0.02 26.75 Dissociation | 2 0.02 26.77 Disturbance in attention | 17 0.17 26.94 Diverticular perforation | 1 0.01 26.95 Diverticulitis | 6 0.06 27.01 Diverticulitis intestinal haemorrhagic | 1 0.01 27.02 Diverticulum | 5 0.05 27.07 Diverticulum intestinal | 1 0.01 27.08 Diverticulum intestinal haemorrhagic | 1 0.01 27.09 Dizziness | 56 0.56 27.65 Dizziness postural | 2 0.02 27.67 Drooling | 1 0.01 27.68 Drug abuse | 12 0.12 27.80 Drug administered at inappropriate site | 2 0.02 27.82 Drug administration error | 3 0.03 27.85 Drug clearance decreased | 1 0.01 27.86 Drug dependence | 9 0.09 27.95 Drug dispensing error | 1 0.01 27.96 Drug diversion | 3 0.03 27.99 Drug dose omission | 34 0.34 28.33 Drug effect decreased | 8 0.08 28.41 Drug effect delayed | 2 0.02 28.43 Drug effect incomplete | 2 0.02 28.45 Drug eruption | 7 0.07 28.52 Drug hypersensitivity | 19 0.19 28.71 Drug ineffective | 77 0.77 29.48 Drug ineffective for unapproved indic.. | 2 0.02 29.50 Drug interaction | 23 0.23 29.73 Drug intolerance | 8 0.08 29.81 Drug label confusion | 1 0.01 29.82 Drug level increased | 2 0.02 29.84 Drug prescribing error | 2 0.02 29.86 Drug reaction with eosinophilia and s.. | 15 0.15 30.01 Drug resistance | 2 0.02 30.03 Drug specific antibody present | 2 0.02 30.05 Drug tolerance | 1 0.01 30.06 Drug withdrawal syndrome | 10 0.10 30.16 Drug withdrawal syndrome neonatal | 8 0.08 30.24 Drug-induced liver injury | 4 0.04 30.28 Dry eye | 3 0.03 30.31 Dry mouth | 13 0.13 30.44 Dry skin | 17 0.17 30.61 Duodenal ulcer | 4 0.04 30.65 Duodenal ulcer perforation | 1 0.01 30.66 Duodenitis | 2 0.02 30.68 Dwarfism | 1 0.01 30.69 Dysaesthesia | 1 0.01 30.70 Dysarthria | 10 0.10 30.80 Dysentery | 1 0.01 30.81 Dysgeusia | 6 0.06 30.87 Dysgraphia | 5 0.05 30.92 Dyskinesia | 10 0.10 31.02 Dysmenorrhoea | 2 0.02 31.04 Dysmorphism | 1 0.01 31.05 Dyspepsia | 8 0.08 31.13 Dysphagia | 12 0.12 31.25 Dysphemia | 2 0.02 31.27 Dysphonia | 14 0.14 31.41 Dysplasia | 1 0.01 31.42 Dysplastic naevus | 1 0.01 31.43 Dyspnoea | 68 0.68 32.11 Dyspnoea at rest | 1 0.01 32.12 Dyspnoea exertional | 3 0.03 32.15 Dyspnoea paroxysmal nocturnal | 1 0.01 32.16 Dysstasia | 8 0.08 32.24 Dystonia | 2 0.02 32.26 Dysuria | 2 0.02 32.28 ELECTROCARDIOGRAM QT PROLONGED | 3 0.03 32.31 ENDOPHTHALMITIS | 1 0.01 32.32 ENTEROBACTER SEPSIS | 1 0.01 32.33 EOSINOPHILIC OESOPHAGITIS | 1 0.01 32.34 EPISTAXIS | 1 0.01 32.35 EPSTEIN-BARR VIRUS INFECTION | 1 0.01 32.36 Ear disorder | 3 0.03 32.39 Ear haemorrhage | 3 0.03 32.42 Ear infection | 4 0.04 32.46 Ear pain | 3 0.03 32.49 Echocardiogram abnormal | 1 0.01 32.50 Economic problem | 9 0.09 32.59 Eczema | 6 0.06 32.65 Eczema asteatotic | 1 0.01 32.66 Ejection fraction decreased | 1 0.01 32.67 Electrocardiogram QRS complex prolonged | 1 0.01 32.68 Electrocardiogram QT prolonged | 13 0.13 32.81 Electrocardiogram T wave abnormal | 1 0.01 32.82 Electrocardiogram abnormal | 1 0.01 32.83 Electrocardiogram repolarisation abno.. | 1 0.01 32.84 Electroencephalogram abnormal | 1 0.01 32.85 Electrolyte imbalance | 4 0.04 32.89 Embolic stroke | 1 0.01 32.90 Embolism | 2 0.02 32.92 Embolism arterial | 1 0.01 32.93 Emotional disorder | 9 0.09 33.02 Emotional distress | 14 0.14 33.16 Emotional poverty | 1 0.01 33.17 Emphysema | 3 0.03 33.20 Encephalitis | 3 0.03 33.23 Encephalopathy | 3 0.03 33.26 Endocarditis | 4 0.04 33.30 Endodontic procedure | 1 0.01 33.31 Endometrial adenocarcinoma | 1 0.01 33.32 Endometrial cancer | 1 0.01 33.33 Endometrial disorder | 1 0.01 33.34 Endometriosis | 2 0.02 33.36 Endotracheal intubation | 1 0.01 33.37 Enteritis | 1 0.01 33.38 Enterobacter infection | 1 0.01 33.39 Enterobacter sepsis | 1 0.01 33.40 Enterococcal infection | 1 0.01 33.41 Enterococcal sepsis | 1 0.01 33.42 Enterocolitis | 1 0.01 33.43 Enterocolitis infectious | 1 0.01 33.44 Eosinophil count decreased | 1 0.01 33.45 Eosinophil count increased | 1 0.01 33.46 Eosinophilia | 7 0.07 33.53 Eosinophilic cellulitis | 1 0.01 33.54 Eosinophilic myocarditis | 1 0.01 33.55 Eosinophilic oesophagitis | 1 0.01 33.56 Eosinophilic pneumonia | 1 0.01 33.57 Epidermal necrosis | 1 0.01 33.58 Epilepsy | 2 0.02 33.60 Epistaxis | 16 0.16 33.76 Epstein-Barr viraemia | 1 0.01 33.77 Epstein-Barr virus infection | 4 0.04 33.81 Erectile dysfunction | 1 0.01 33.82 Erosive oesophagitis | 1 0.01 33.83 Erysipelas | 2 0.02 33.85 Erythema | 26 0.26 34.11 Erythema induratum | 1 0.01 34.12 Erythema multiforme | 2 0.02 34.14 Erythema nodosum | 1 0.01 34.15 Erythrodermic psoriasis | 2 0.02 34.17 Erythropenia | 1 0.01 34.18 Eschar | 1 0.01 34.19 Escherichia bacteraemia | 1 0.01 34.20 Escherichia infection | 2 0.02 34.22 Escherichia sepsis | 2 0.02 34.24 Escherichia urinary tract infection | 2 0.02 34.26 Euphoric mood | 2 0.02 34.28 Excessive eye blinking | 1 0.01 34.29 Excessive granulation tissue | 1 0.01 34.30 Excoriation | 5 0.05 34.35 Exfoliative rash | 2 0.02 34.37 Exomphalos | 1 0.01 34.38 Exostosis | 1 0.01 34.39 Exostosis of jaw | 1 0.01 34.40 Expired drug administered | 4 0.04 34.44 Exposed bone in jaw | 2 0.02 34.46 Exposure during breast feeding | 3 0.03 34.49 Exposure during pregnancy | 54 0.54 35.03 Exposure via body fluid | 3 0.03 35.06 Exsanguination | 1 0.01 35.07 Extensive swelling of vaccinated limb | 1 0.01 35.08 Extrapyramidal disorder | 8 0.08 35.16 Extrasystoles | 2 0.02 35.18 Extremity contracture | 1 0.01 35.19 Extremity necrosis | 1 0.01 35.20 Eye disorder | 7 0.07 35.27 Eye infection | 1 0.01 35.28 Eye irritation | 3 0.03 35.31 Eye movement disorder | 7 0.07 35.38 Eye operation complication | 1 0.01 35.39 Eye pain | 3 0.03 35.42 Eyelid bleeding | 1 0.01 35.43 Eyelid function disorder | 1 0.01 35.44 Eyelid oedema | 3 0.03 35.47 Eyelid ptosis | 1 0.01 35.48 FACE OEDEMA | 1 0.01 35.49 FALL | 2 0.02 35.51 FATIGUE | 1 0.01 35.52 FEELING COLD | 1 0.01 35.53 FIBRIN D DIMER INCREASED | 1 0.01 35.54 FLAT ANTERIOR CHAMBER OF EYE | 1 0.01 35.55 FLUID OVERLOAD | 1 0.01 35.56 Face oedema | 7 0.07 35.63 Facet joint syndrome | 2 0.02 35.65 Facial pain | 1 0.01 35.66 Factor VIII inhibition | 1 0.01 35.67 Faecal incontinence | 5 0.05 35.72 Faecal vomiting | 2 0.02 35.74 Faeces pale | 1 0.01 35.75 Fall | 74 0.74 36.49 Fallopian tube cyst | 1 0.01 36.50 Fallot's tetralogy | 1 0.01 36.51 Fat embolism | 1 0.01 36.52 Fatigue | 121 1.21 37.73 Fear | 8 0.08 37.81 Fear of death | 1 0.01 37.82 Febrile neutropenia | 8 0.08 37.90 Feeling abnormal | 27 0.27 38.17 Feeling cold | 4 0.04 38.21 Feeling guilty | 1 0.01 38.22 Feeling hot | 15 0.15 38.37 Feeling jittery | 4 0.04 38.41 Feeling of body temperature change | 1 0.01 38.42 Feeling of despair | 1 0.01 38.43 Female genital tract fistula | 1 0.01 38.44 Femoral neck fracture | 2 0.02 38.46 Femur fracture | 5 0.05 38.51 Fibrocystic breast disease | 1 0.01 38.52 Fibromyalgia | 6 0.06 38.58 Fibrosis | 1 0.01 38.59 Fibula fracture | 1 0.01 38.60 Finger deformity | 2 0.02 38.62 Fistula | 1 0.01 38.63 Fistula discharge | 1 0.01 38.64 Flank pain | 2 0.02 38.66 Flashback | 1 0.01 38.67 Flatulence | 1 0.01 38.68 Fluid retention | 12 0.12 38.80 Flushing | 12 0.12 38.92 Focal segmental glomerulosclerosis | 1 0.01 38.93 Foetal chromosome abnormality | 1 0.01 38.94 Foetal cystic hygroma | 1 0.01 38.95 Foetal death | 4 0.04 38.99 Foetal disorder | 1 0.01 39.00 Foetal exposure during pregnancy | 39 0.39 39.39 Foetal growth restriction | 3 0.03 39.42 Foetal heart rate abnormal | 3 0.03 39.45 Foetal heart rate deceleration | 1 0.01 39.46 Foetal non-stress test abnormal | 1 0.01 39.47 Folate deficiency | 1 0.01 39.48 Follicle centre lymphoma, follicular .. | 1 0.01 39.49 Follicular mucinosis | 1 0.01 39.50 Folliculitis | 2 0.02 39.52 Food allergy | 1 0.01 39.53 Food craving | 1 0.01 39.54 Foot deformity | 4 0.04 39.58 Foot fracture | 6 0.06 39.64 Forceps delivery | 1 0.01 39.65 Foreign body | 1 0.01 39.66 Formication | 2 0.02 39.68 Fracture | 1 0.01 39.69 Fracture nonunion | 1 0.01 39.70 Frequent bowel movements | 3 0.03 39.73 Frustration | 2 0.02 39.75 Full blood count abnormal | 1 0.01 39.76 Functional gastrointestinal disorder | 1 0.01 39.77 Fungal infection | 7 0.07 39.84 Fungal skin infection | 1 0.01 39.85 GALACTORRHOEA | 1 0.01 39.86 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 1 0.01 39.87 GASTRITIS EROSIVE | 1 0.01 39.88 GASTROENTERITIS | 1 0.01 39.89 GINGIVAL SWELLING | 1 0.01 39.90 GRAND MAL CONVULSION | 1 0.01 39.91 Gait disturbance | 54 0.54 40.45 Galactorrhoea | 2 0.02 40.47 Gallbladder disorder | 10 0.10 40.57 Gallbladder injury | 1 0.01 40.58 Gallbladder operation | 1 0.01 40.59 Gallbladder perforation | 1 0.01 40.60 Gallbladder polyp | 1 0.01 40.61 Gamma-glutamyltransferase abnormal | 1 0.01 40.62 Gamma-glutamyltransferase increased | 10 0.10 40.72 Gangrene | 1 0.01 40.73 Gastric bypass | 1 0.01 40.74 Gastric disorder | 8 0.08 40.82 Gastric haemorrhage | 2 0.02 40.84 Gastric pH decreased | 1 0.01 40.85 Gastric polyps | 1 0.01 40.86 Gastric ulcer | 8 0.08 40.94 Gastric ulcer haemorrhage | 2 0.02 40.96 Gastritis | 6 0.06 41.02 Gastritis erosive | 1 0.01 41.03 Gastritis haemorrhagic | 1 0.01 41.04 Gastroenteritis | 2 0.02 41.06 Gastroenteritis bacterial | 1 0.01 41.07 Gastroenteritis norovirus | 1 0.01 41.08 Gastroenteritis radiation | 1 0.01 41.09 Gastroenteritis viral | 3 0.03 41.12 Gastrointestinal disorder | 7 0.07 41.19 Gastrointestinal haemorrhage | 13 0.13 41.32 Gastrointestinal hypomotility | 2 0.02 41.34 Gastrointestinal inflammation | 1 0.01 41.35 Gastrointestinal injury | 9 0.09 41.44 Gastrointestinal necrosis | 2 0.02 41.46 Gastrointestinal pain | 3 0.03 41.49 Gastrointestinal perforation | 1 0.01 41.50 Gastrointestinal tract irritation | 1 0.01 41.51 Gastrooesophageal reflux disease | 24 0.24 41.75 Gaze palsy | 2 0.02 41.77 General physical condition abnormal | 2 0.02 41.79 General physical health deterioration | 16 0.16 41.95 General symptom | 5 0.05 42.00 Generalised oedema | 4 0.04 42.04 Genital haemorrhage | 2 0.02 42.06 Genital herpes | 1 0.01 42.07 Gestational diabetes | 2 0.02 42.09 Gingival abscess | 2 0.02 42.11 Gingival bleeding | 1 0.01 42.12 Gingival disorder | 1 0.01 42.13 Gingival infection | 1 0.01 42.14 Gingival pain | 4 0.04 42.18 Gingival swelling | 2 0.02 42.20 Glaucoma | 7 0.07 42.27 Gleich's syndrome | 1 0.01 42.28 Gliosis | 2 0.02 42.30 Glomerular filtration rate decreased | 1 0.01 42.31 Glomerulonephritis | 1 0.01 42.32 Glomerulonephritis minimal lesion | 1 0.01 42.33 Glomerulonephritis rapidly progressive | 1 0.01 42.34 Glossitis | 2 0.02 42.36 Glossodynia | 1 0.01 42.37 Glucose tolerance impaired | 2 0.02 42.39 Glycosuria | 1 0.01 42.40 Glycosylated haemoglobin increased | 4 0.04 42.44 Goitre | 1 0.01 42.45 Graft complication | 1 0.01 42.46 Graft versus host disease | 4 0.04 42.50 Gram stain positive | 1 0.01 42.51 Grand mal convulsion | 8 0.08 42.59 Granulocytopenia | 1 0.01 42.60 Granuloma skin | 1 0.01 42.61 Grimacing | 1 0.01 42.62 Groin pain | 3 0.03 42.65 Growth retardation | 1 0.01 42.66 Guttate psoriasis | 1 0.01 42.67 Gynaecomastia | 2 0.02 42.69 H1N1 influenza | 1 0.01 42.70 HAEMORRHOIDS | 1 0.01 42.71 HEART RATE DECREASED | 1 0.01 42.72 HEPATIC ENZYME INCREASED | 1 0.01 42.73 HEPATITIS | 1 0.01 42.74 HEPATITIS CHOLESTATIC | 1 0.01 42.75 HEPATOMEGALY | 1 0.01 42.76 HEPATOTOXICITY | 1 0.01 42.77 HEREDITARY ANGIOEDEMA | 1 0.01 42.78 HUMAN HERPESVIRUS 6 INFECTION | 1 0.01 42.79 HYPERHIDROSIS | 1 0.01 42.80 HYPERTONIA | 1 0.01 42.81 HYPONATRAEMIA | 2 0.02 42.83 HYPOPNOEA | 1 0.01 42.84 HYPOPYON | 1 0.01 42.85 HYPOTENSION | 2 0.02 42.87 Haemangioma | 2 0.02 42.89 Haemangioma of liver | 1 0.01 42.90 Haemarthrosis | 1 0.01 42.91 Haematemesis | 6 0.06 42.97 Haematochezia | 9 0.09 43.06 Haematocrit decreased | 4 0.04 43.10 Haematoma | 4 0.04 43.14 Haematotoxicity | 4 0.04 43.18 Haematuria | 3 0.03 43.21 Haemodialysis | 1 0.01 43.22 Haemoglobin abnormal | 1 0.01 43.23 Haemoglobin decreased | 18 0.18 43.41 Haemoglobin increased | 1 0.01 43.42 Haemolysis | 3 0.03 43.45 Haemolytic anaemia | 1 0.01 43.46 Haemoptysis | 5 0.05 43.51 Haemorrhage | 5 0.05 43.56 Haemorrhage in pregnancy | 4 0.04 43.60 Haemorrhage intracranial | 2 0.02 43.62 Haemorrhage urinary tract | 2 0.02 43.64 Haemorrhagic anaemia | 1 0.01 43.65 Haemorrhagic diathesis | 1 0.01 43.66 Haemorrhagic stroke | 2 0.02 43.68 Haemorrhoidal haemorrhage | 1 0.01 43.69 Haemorrhoids | 6 0.06 43.75 Hair colour changes | 1 0.01 43.76 Hair growth abnormal | 1 0.01 43.77 Hair texture abnormal | 1 0.01 43.78 Hallucination | 11 0.11 43.89 Hallucination, auditory | 1 0.01 43.90 Hallucination, visual | 4 0.04 43.94 Hallucinations, mixed | 3 0.03 43.97 Hand-foot-and-mouth disease | 1 0.01 43.98 Hangover | 1 0.01 43.99 Head discomfort | 1 0.01 44.00 Head injury | 6 0.06 44.06 Headache | 82 0.82 44.88 Hearing impaired | 7 0.07 44.95 Heart disease congenital | 3 0.03 44.98 Heart rate decreased | 2 0.02 45.00 Heart rate increased | 4 0.04 45.04 Heart rate irregular | 5 0.05 45.09 Heart valve incompetence | 2 0.02 45.11 Helicobacter infection | 1 0.01 45.12 Hemiparesis | 11 0.11 45.23 Hemiplegia | 1 0.01 45.24 Hepatic adenoma | 2 0.02 45.26 Hepatic cancer | 4 0.04 45.30 Hepatic cirrhosis | 6 0.06 45.36 Hepatic encephalopathy | 4 0.04 45.40 Hepatic enzyme increased | 4 0.04 45.44 Hepatic failure | 8 0.08 45.52 Hepatic function abnormal | 11 0.11 45.63 Hepatic haemorrhage | 1 0.01 45.64 Hepatic mass | 1 0.01 45.65 Hepatic necrosis | 1 0.01 45.66 Hepatic neoplasm | 1 0.01 45.67 Hepatic steatosis | 3 0.03 45.70 Hepatitis B | 2 0.02 45.72 Hepatitis C | 4 0.04 45.76 Hepatitis acute | 1 0.01 45.77 Hepatitis viral | 1 0.01 45.78 Hepatocellular carcinoma | 7 0.07 45.85 Hepatocellular injury | 7 0.07 45.92 Hepatojugular reflux | 1 0.01 45.93 Hepatomegaly | 3 0.03 45.96 Hepatosplenic T-cell lymphoma | 3 0.03 45.99 Hepatosplenomegaly | 1 0.01 46.00 Hepatotoxicity | 3 0.03 46.03 Hernia | 3 0.03 46.06 Hernia congenital | 1 0.01 46.07 Hernia obstructive | 1 0.01 46.08 Herpes oesophagitis | 1 0.01 46.09 Herpes pharyngitis | 1 0.01 46.10 Herpes simplex | 2 0.02 46.12 Herpes zoster | 5 0.05 46.17 Hiatus hernia | 9 0.09 46.26 Hiccups | 1 0.01 46.27 High density lipoprotein decreased | 1 0.01 46.28 Hip arthroplasty | 2 0.02 46.30 Hip fracture | 7 0.07 46.37 Hirsutism | 1 0.01 46.38 Histiocytosis haematophagic | 1 0.01 46.39 Hodgkin's disease | 1 0.01 46.40 Hodgkin's disease nodular sclerosis s.. | 1 0.01 46.41 Homans' sign positive | 1 0.01 46.42 Homicidal ideation | 4 0.04 46.46 Homicide | 4 0.04 46.50 Hospitalisation | 1 0.01 46.51 Hot flush | 8 0.08 46.59 Human chorionic gonadotropin increased | 1 0.01 46.60 Human herpesvirus 6 infection | 1 0.01 46.61 Human papilloma virus test positive | 1 0.01 46.62 Humerus fracture | 1 0.01 46.63 Hunger | 3 0.03 46.66 Hydronephrosis | 2 0.02 46.68 Hydropneumothorax | 1 0.01 46.69 Hyperaesthesia | 2 0.02 46.71 Hyperammonaemia | 2 0.02 46.73 Hyperbilirubinaemia | 2 0.02 46.75 Hypercalcaemia | 5 0.05 46.80 Hypercapnia | 1 0.01 46.81 Hyperchlorhydria | 2 0.02 46.83 Hypercholesterolaemia | 2 0.02 46.85 Hypercoagulation | 1 0.01 46.86 Hyperdynamic left ventricle | 1 0.01 46.87 Hypergammaglobulinaemia benign monocl.. | 1 0.01 46.88 Hyperglycaemia | 13 0.13 47.01 Hyperhidrosis | 18 0.18 47.19 Hyperkalaemia | 8 0.08 47.27 Hyperkeratosis | 4 0.04 47.31 Hyperlipidaemia | 4 0.04 47.35 Hypernatraemia | 1 0.01 47.36 Hyperphagia | 2 0.02 47.38 Hyperprolactinaemia | 1 0.01 47.39 Hyperreflexia | 1 0.01 47.40 Hypersensitivity | 15 0.15 47.55 Hypersexuality | 1 0.01 47.56 Hypersomnia | 6 0.06 47.62 Hypertension | 44 0.44 48.06 Hypertension neonatal | 1 0.01 48.07 Hypertensive crisis | 2 0.02 48.09 Hypertensive emergency | 1 0.01 48.10 Hypertensive heart disease | 1 0.01 48.11 Hyperthermia | 3 0.03 48.14 Hyperthyroidism | 4 0.04 48.18 Hypertonia | 1 0.01 48.19 Hypertonic bladder | 2 0.02 48.21 Hypertriglyceridaemia | 1 0.01 48.22 Hyperuricaemia | 1 0.01 48.23 Hyperventilation | 6 0.06 48.29 Hypoacusis | 6 0.06 48.35 Hypoaesthesia | 43 0.43 48.78 Hypoalbuminaemia | 3 0.03 48.81 Hypocalcaemia | 5 0.05 48.86 Hypogammaglobulinaemia | 1 0.01 48.87 Hypoglycaemia | 9 0.09 48.96 Hypoglycaemia neonatal | 1 0.01 48.97 Hypohidrosis | 2 0.02 48.99 Hypokalaemia | 8 0.08 49.07 Hypokinesia | 1 0.01 49.08 Hypomagnesaemia | 3 0.03 49.11 Hypomania | 2 0.02 49.13 Hyponatraemia | 6 0.06 49.19 Hypophagia | 7 0.07 49.26 Hypophosphataemia | 3 0.03 49.29 Hypoproteinaemia | 1 0.01 49.30 Hypoprothrombinaemia | 1 0.01 49.31 Hypospadias | 1 0.01 49.32 Hypotension | 27 0.27 49.59 Hypothermia | 1 0.01 49.60 Hypothyroidism | 5 0.05 49.65 Hypotonia | 2 0.02 49.67 Hypoventilation | 1 0.01 49.68 Hypovolaemic shock | 3 0.03 49.71 Hypoxia | 6 0.06 49.77 Hysterectomy | 2 0.02 49.79 IDIOSYNCRATIC DRUG REACTION | 1 0.01 49.80 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 1 0.01 49.81 INFECTION | 1 0.01 49.82 INTENTIONAL OVERDOSE | 1 0.01 49.83 INTERSTITIAL LUNG DISEASE | 2 0.02 49.85 Ichthyosis | 1 0.01 49.86 Idiosyncratic drug reaction | 5 0.05 49.91 IgA nephropathy | 3 0.03 49.94 Ileostomy | 1 0.01 49.95 Ileus | 3 0.03 49.98 Ileus paralytic | 3 0.03 50.01 Ill-defined disorder | 2 0.02 50.03 Immune reconstitution inflammatory sy.. | 5 0.05 50.08 Immunosuppressant drug level increased | 4 0.04 50.12 Immunosuppression | 1 0.01 50.13 Impaired driving ability | 4 0.04 50.17 Impaired gastric emptying | 3 0.03 50.20 Impaired healing | 16 0.16 50.36 Impaired self-care | 3 0.03 50.39 Impaired work ability | 3 0.03 50.42 Imprisonment | 1 0.01 50.43 Inappropriate affect | 1 0.01 50.44 Inappropriate schedule of drug admini.. | 5 0.05 50.49 Incisional hernia | 1 0.01 50.50 Incoherent | 4 0.04 50.54 Incontinence | 4 0.04 50.58 Incorrect dose administered | 11 0.11 50.69 Incorrect drug administration duration | 3 0.03 50.72 Incorrect drug administration rate | 1 0.01 50.73 Increased appetite | 2 0.02 50.75 Increased tendency to bruise | 1 0.01 50.76 Increased upper airway secretion | 4 0.04 50.80 Induced labour | 1 0.01 50.81 Induration | 1 0.01 50.82 Infarction | 2 0.02 50.84 Infected cyst | 1 0.01 50.85 Infection | 22 0.22 51.07 Infection parasitic | 1 0.01 51.08 Infectious mononucleosis | 2 0.02 51.10 Infertility male | 1 0.01 51.11 Inflammation | 7 0.07 51.18 Inflammatory bowel disease | 18 0.18 51.36 Inflammatory marker increased | 2 0.02 51.38 Influenza | 15 0.15 51.53 Influenza like illness | 31 0.31 51.84 Infusion related reaction | 6 0.06 51.90 Infusion site bruising | 1 0.01 51.91 Infusion site extravasation | 1 0.01 51.92 Infusion site pain | 2 0.02 51.94 Infusion site scar | 1 0.01 51.95 Ingrowing nail | 1 0.01 51.96 Ingrown hair | 1 0.01 51.97 Inguinal hernia | 1 0.01 51.98 Inhibitory drug interaction | 1 0.01 51.99 Initial insomnia | 2 0.02 52.01 Injection site atrophy | 1 0.01 52.02 Injection site bruising | 17 0.17 52.19 Injection site cellulitis | 1 0.01 52.20 Injection site discolouration | 3 0.03 52.23 Injection site erythema | 14 0.14 52.37 Injection site extravasation | 3 0.03 52.40 Injection site haemorrhage | 7 0.07 52.47 Injection site hypersensitivity | 1 0.01 52.48 Injection site induration | 2 0.02 52.50 Injection site inflammation | 1 0.01 52.51 Injection site mass | 5 0.05 52.56 Injection site nodule | 2 0.02 52.58 Injection site oedema | 1 0.01 52.59 Injection site pain | 48 0.48 53.07 Injection site papule | 1 0.01 53.08 Injection site pruritus | 9 0.09 53.17 Injection site rash | 3 0.03 53.20 Injection site reaction | 4 0.04 53.24 Injection site swelling | 6 0.06 53.30 Injection site urticaria | 3 0.03 53.33 Injection site vesicles | 1 0.01 53.34 Injection site warmth | 2 0.02 53.36 Injury | 20 0.20 53.56 Injury associated with device | 7 0.07 53.63 Inner ear disorder | 1 0.01 53.64 Insomnia | 36 0.36 54.00 Intentional drug misuse | 16 0.16 54.16 Intentional overdose | 18 0.18 54.34 Intentional self-injury | 4 0.04 54.38 International normalised ratio decrea.. | 1 0.01 54.39 International normalised ratio increa.. | 2 0.02 54.41 Interstitial lung disease | 10 0.10 54.51 Intervertebral disc compression | 1 0.01 54.52 Intervertebral disc degeneration | 7 0.07 54.59 Intervertebral disc disorder | 1 0.01 54.60 Intervertebral disc injury | 1 0.01 54.61 Intervertebral disc protrusion | 10 0.10 54.71 Intervertebral disc space narrowing | 2 0.02 54.73 Intervertebral discitis | 2 0.02 54.75 Intestinal haemorrhage | 1 0.01 54.76 Intestinal infarction | 2 0.02 54.78 Intestinal obstruction | 10 0.10 54.88 Intestinal perforation | 3 0.03 54.91 Intestinal polyp | 2 0.02 54.93 Intestinal resection | 1 0.01 54.94 Intestinal stenosis | 1 0.01 54.95 Intestinal ulcer | 1 0.01 54.96 Intracardiac thrombus | 2 0.02 54.98 Intracranial aneurysm | 4 0.04 55.02 Intracranial pressure increased | 2 0.02 55.04 Intracranial venous sinus thrombosis | 2 0.02 55.06 Intraductal proliferative breast lesion | 2 0.02 55.08 Intraocular melanoma | 1 0.01 55.09 Intraocular pressure increased | 1 0.01 55.10 Intravascular haemolysis | 1 0.01 55.11 Invasive ductal breast carcinoma | 2 0.02 55.13 Iodine deficiency | 1 0.01 55.14 Iritis | 2 0.02 55.16 Iron deficiency anaemia | 1 0.01 55.17 Iron overload | 1 0.01 55.18 Irritability | 11 0.11 55.29 Irritable bowel syndrome | 11 0.11 55.40 Ischaemia | 1 0.01 55.41 Ischaemic cardiomyopathy | 1 0.01 55.42 Ischaemic cerebral infarction | 1 0.01 55.43 Ischaemic hepatitis | 2 0.02 55.45 Ischaemic stroke | 1 0.01 55.46 JC virus infection | 1 0.01 55.47 JC virus test positive | 1 0.01 55.48 JOINT STIFFNESS | 1 0.01 55.49 Jaundice | 6 0.06 55.55 Jaundice neonatal | 3 0.03 55.58 Jaw cyst | 1 0.01 55.59 Jaw fracture | 1 0.01 55.60 Joint arthroplasty | 1 0.01 55.61 Joint contracture | 4 0.04 55.65 Joint crepitation | 2 0.02 55.67 Joint dislocation | 4 0.04 55.71 Joint effusion | 1 0.01 55.72 Joint injury | 7 0.07 55.79 Joint range of motion decreased | 9 0.09 55.88 Joint stiffness | 6 0.06 55.94 Joint swelling | 15 0.15 56.09 Judgement impaired | 1 0.01 56.10 Jugular vein thrombosis | 1 0.01 56.11 KLEBSIELLA SEPSIS | 1 0.01 56.12 Karnofsky scale worsened | 1 0.01 56.13 Karyotype analysis abnormal | 1 0.01 56.14 Keratitis | 1 0.01 56.15 Keratoconus | 1 0.01 56.16 Ketoacidosis | 1 0.01 56.17 Kidney fibrosis | 1 0.01 56.18 Kidney infection | 2 0.02 56.20 Kidney transplant rejection | 6 0.06 56.26 Klebsiella infection | 1 0.01 56.27 Klebsiella sepsis | 1 0.01 56.28 Klinefelter's syndrome | 1 0.01 56.29 Knee arthroplasty | 3 0.03 56.32 Kyphoscoliosis | 1 0.01 56.33 Kyphosis | 1 0.01 56.34 LEFT VENTRICULAR FAILURE | 1 0.01 56.35 LETHARGY | 3 0.03 56.38 LEUKOCYTOSIS | 1 0.01 56.39 LOSS OF CONSCIOUSNESS | 1 0.01 56.40 LUNG NEOPLASM | 1 0.01 56.41 LYMPHADENOPATHY | 1 0.01 56.42 Labile hypertension | 1 0.01 56.43 Laboratory test abnormal | 1 0.01 56.44 Laceration | 9 0.09 56.53 Lacrimation increased | 1 0.01 56.54 Lactic acidosis | 4 0.04 56.58 Large intestine perforation | 4 0.04 56.62 Large intestine polyp | 4 0.04 56.66 Laryngeal oedema | 2 0.02 56.68 Laryngitis | 1 0.01 56.69 Learning disorder | 1 0.01 56.70 Left atrial dilatation | 1 0.01 56.71 Left ventricular dysfunction | 1 0.01 56.72 Left ventricular hypertrophy | 3 0.03 56.75 Leg amputation | 2 0.02 56.77 Leiomyoma | 3 0.03 56.80 Lentigo | 1 0.01 56.81 Lethargy | 13 0.13 56.94 Leukaemia | 2 0.02 56.96 Leukaemic infiltration brain | 1 0.01 56.97 Leukocytosis | 4 0.04 57.01 Leukoencephalopathy | 4 0.04 57.05 Leukopenia | 6 0.06 57.11 Libido decreased | 2 0.02 57.13 Libido increased | 1 0.01 57.14 Lichen planus | 1 0.01 57.15 Lichenoid keratosis | 2 0.02 57.17 Ligament disorder | 1 0.01 57.18 Ligament injury | 1 0.01 57.19 Ligament rupture | 3 0.03 57.22 Ligament sprain | 6 0.06 57.28 Limb asymmetry | 1 0.01 57.29 Limb crushing injury | 1 0.01 57.30 Limb discomfort | 3 0.03 57.33 Limb injury | 1 0.01 57.34 Lip disorder | 1 0.01 57.35 Lip dry | 8 0.08 57.43 Lip oedema | 1 0.01 57.44 Lip swelling | 3 0.03 57.47 Lipase increased | 3 0.03 57.50 Lipid metabolism disorder | 2 0.02 57.52 Lipoma | 1 0.01 57.53 Liquid product physical issue | 1 0.01 57.54 Listless | 1 0.01 57.55 Liver disorder | 7 0.07 57.62 Liver function test abnormal | 6 0.06 57.68 Liver injury | 1 0.01 57.69 Liver tenderness | 1 0.01 57.70 Liver transplant | 2 0.02 57.72 Lobar pneumonia | 2 0.02 57.74 Local reaction | 1 0.01 57.75 Local swelling | 33 0.33 58.08 Localised infection | 2 0.02 58.10 Localised intraabdominal fluid collec.. | 1 0.01 58.11 Localised oedema | 1 0.01 58.12 Logorrhoea | 1 0.01 58.13 Loose tooth | 1 0.01 58.14 Loss of consciousness | 19 0.19 58.33 Loss of control of legs | 2 0.02 58.35 Loss of employment | 1 0.01 58.36 Loss of proprioception | 1 0.01 58.37 Low birth weight baby | 2 0.02 58.39 Low cardiac output syndrome | 1 0.01 58.40 Low density lipoprotein abnormal | 1 0.01 58.41 Low density lipoprotein increased | 2 0.02 58.43 Lower extremity mass | 1 0.01 58.44 Lower limb fracture | 7 0.07 58.51 Lower respiratory tract infection | 6 0.06 58.57 Lumbar spinal stenosis | 3 0.03 58.60 Lumbar vertebral fracture | 1 0.01 58.61 Lung adenocarcinoma | 1 0.01 58.62 Lung adenocarcinoma stage IV | 1 0.01 58.63 Lung consolidation | 1 0.01 58.64 Lung disorder | 10 0.10 58.74 Lung hyperinflation | 1 0.01 58.75 Lung infection | 4 0.04 58.79 Lung infiltration | 4 0.04 58.83 Lung neoplasm | 2 0.02 58.85 Lung neoplasm malignant | 5 0.05 58.90 Lupus-like syndrome | 1 0.01 58.91 Lyme disease | 1 0.01 58.92 Lymph node pain | 1 0.01 58.93 Lymphadenitis | 3 0.03 58.96 Lymphadenopathy | 7 0.07 59.03 Lymphadenopathy mediastinal | 1 0.01 59.04 Lymphangitis | 1 0.01 59.05 Lymphocele | 1 0.01 59.06 Lymphocyte count decreased | 3 0.03 59.09 Lymphocyte count increased | 1 0.01 59.10 Lymphocytic infiltration | 1 0.01 59.11 Lymphoedema | 4 0.04 59.15 Lymphoid tissue hyperplasia | 1 0.01 59.16 Lymphoma | 6 0.06 59.22 Lymphoproliferative disorder | 1 0.01 59.23 MALIGNANT MELANOMA | 1 0.01 59.24 MATERNAL EXPOSURE DURING PREGNANCY | 2 0.02 59.26 MELAENA | 1 0.01 59.27 MEMORY IMPAIRMENT | 2 0.02 59.29 MENTAL STATUS CHANGES | 1 0.01 59.30 MOOD ALTERED | 1 0.01 59.31 MOOD SWINGS | 1 0.01 59.32 MOVEMENT DISORDER | 1 0.01 59.33 MULTI-ORGAN FAILURE | 1 0.01 59.34 MUSCLE TWITCHING | 2 0.02 59.36 MUSCULOSKELETAL STIFFNESS | 1 0.01 59.37 MYOCLONUS | 1 0.01 59.38 Macular oedema | 1 0.01 59.39 Macule | 1 0.01 59.40 Major depression | 5 0.05 59.45 Malaise | 64 0.64 60.09 Malignant melanoma | 7 0.07 60.16 Malignant neoplasm progression | 20 0.20 60.36 Malignant pleural effusion | 1 0.01 60.37 Malignant respiratory tract neoplasm | 1 0.01 60.38 Malnutrition | 2 0.02 60.40 Mania | 1 0.01 60.41 Masked facies | 1 0.01 60.42 Mass | 4 0.04 60.46 Mastication disorder | 1 0.01 60.47 Mastitis | 1 0.01 60.48 Maternal drugs affecting foetus | 6 0.06 60.54 Maternal exposure during pregnancy | 6 0.06 60.60 Mean cell volume abnormal | 1 0.01 60.61 Mean cell volume decreased | 1 0.01 60.62 Mean platelet volume decreased | 1 0.01 60.63 Mechanical urticaria | 1 0.01 60.64 Meconium plug syndrome | 1 0.01 60.65 Meconium stain | 1 0.01 60.66 Medical device complication | 2 0.02 60.68 Medical device removal | 1 0.01 60.69 Medication error | 6 0.06 60.75 Melaena | 5 0.05 60.80 Melanocytic hyperplasia | 1 0.01 60.81 Melanoma recurrent | 1 0.01 60.82 Memory impairment | 33 0.33 61.15 Meningism | 1 0.01 61.16 Meningitis | 1 0.01 61.17 Meningitis listeria | 1 0.01 61.18 Meningitis meningococcal | 1 0.01 61.19 Meningococcal sepsis | 2 0.02 61.21 Meningoencephalitis herpetic | 1 0.01 61.22 Meniscus injury | 4 0.04 61.26 Menorrhagia | 1 0.01 61.27 Menstrual disorder | 3 0.03 61.30 Menstruation delayed | 1 0.01 61.31 Menstruation irregular | 2 0.02 61.33 Mental disorder | 14 0.14 61.47 Mental impairment | 11 0.11 61.58 Mental retardation | 1 0.01 61.59 Mental status changes | 8 0.08 61.67 Mesenteritis | 1 0.01 61.68 Metabolic acidosis | 11 0.11 61.79 Metabolic disorder | 2 0.02 61.81 Metabolic encephalopathy | 1 0.01 61.82 Metastases to bone | 4 0.04 61.86 Metastases to central nervous system | 3 0.03 61.89 Metastases to chest wall | 1 0.01 61.90 Metastases to eye | 1 0.01 61.91 Metastases to liver | 6 0.06 61.97 Metastases to lung | 5 0.05 62.02 Metastases to lymph nodes | 2 0.02 62.04 Metastases to peritoneum | 2 0.02 62.06 Metastases to retroperitoneum | 1 0.01 62.07 Metastases to spine | 1 0.01 62.08 Metastasis | 3 0.03 62.11 Metastatic neoplasm | 2 0.02 62.13 Metrorrhagia | 1 0.01 62.14 Microcytic anaemia | 1 0.01 62.15 Micturition urgency | 2 0.02 62.17 Middle insomnia | 1 0.01 62.18 Migraine | 14 0.14 62.32 Migraine with aura | 2 0.02 62.34 Miosis | 3 0.03 62.37 Mitral valve disease | 1 0.01 62.38 Mitral valve incompetence | 2 0.02 62.40 Mobility decreased | 22 0.22 62.62 Monocytosis | 1 0.01 62.63 Monoparesis | 1 0.01 62.64 Monoplegia | 1 0.01 62.65 Mood altered | 3 0.03 62.68 Motor dysfunction | 2 0.02 62.70 Mouth breathing | 1 0.01 62.71 Mouth haemorrhage | 2 0.02 62.73 Mouth injury | 1 0.01 62.74 Mouth ulceration | 1 0.01 62.75 Movement disorder | 3 0.03 62.78 Mucopolysaccharidosis I | 1 0.01 62.79 Mucosal dryness | 1 0.01 62.80 Mucosal inflammation | 5 0.05 62.85 Multi-organ disorder | 1 0.01 62.86 Multi-organ failure | 11 0.11 62.97 Multiple congenital abnormalities | 2 0.02 62.99 Multiple fractures | 2 0.02 63.01 Multiple injuries | 3 0.03 63.04 Multiple sclerosis | 23 0.23 63.27 Multiple sclerosis relapse | 33 0.33 63.60 Muscle atrophy | 5 0.05 63.65 Muscle contractions involuntary | 1 0.01 63.66 Muscle contracture | 1 0.01 63.67 Muscle disorder | 2 0.02 63.69 Muscle fibrosis | 1 0.01 63.70 Muscle injury | 1 0.01 63.71 Muscle rigidity | 3 0.03 63.74 Muscle rupture | 3 0.03 63.77 Muscle spasms | 29 0.29 64.06 Muscle spasticity | 5 0.05 64.11 Muscle strain | 4 0.04 64.15 Muscle tightness | 3 0.03 64.18 Muscle twitching | 5 0.05 64.23 Muscular weakness | 43 0.43 64.66 Musculoskeletal chest pain | 1 0.01 64.67 Musculoskeletal discomfort | 5 0.05 64.72 Musculoskeletal disorder | 7 0.07 64.79 Musculoskeletal pain | 8 0.08 64.87 Musculoskeletal stiffness | 14 0.14 65.01 Mutism | 1 0.01 65.02 Myalgia | 23 0.23 65.25 Mycoplasma infection | 1 0.01 65.26 Mycoplasma test positive | 1 0.01 65.27 Mycosis fungoides | 1 0.01 65.28 Mydriasis | 2 0.02 65.30 Myelodysplastic syndrome | 3 0.03 65.33 Myelopathy | 1 0.01 65.34 Myocardial infarction | 25 0.25 65.59 Myocardial ischaemia | 3 0.03 65.62 Myocarditis | 1 0.01 65.63 Myoclonus | 5 0.05 65.68 Myoglobin blood increased | 1 0.01 65.69 Myopathy | 2 0.02 65.71 Myosclerosis | 1 0.01 65.72 Myxoedema coma | 1 0.01 65.73 N-telopeptide urine increased | 1 0.01 65.74 NAUSEA | 2 0.02 65.76 NEOPLASM MALIGNANT | 1 0.01 65.77 NERVOUS SYSTEM DISORDER | 1 0.01 65.78 NEUTRALISING ANTIBODIES POSITIVE | 1 0.01 65.79 NEUTROPHILIA | 1 0.01 65.80 NO THERAPEUTIC RESPONSE | 1 0.01 65.81 Nail avulsion | 1 0.01 65.82 Nail disorder | 2 0.02 65.84 Nail hypertrophy | 1 0.01 65.85 Nail injury | 1 0.01 65.86 Nail psoriasis | 1 0.01 65.87 Nasal congestion | 5 0.05 65.92 Nasal disorder | 1 0.01 65.93 Nasal dryness | 3 0.03 65.96 Nasal polyps | 1 0.01 65.97 Nasal septum deviation | 1 0.01 65.98 Nasal ulcer | 2 0.02 66.00 Nasopharyngitis | 28 0.28 66.28 Nausea | 74 0.74 67.02 Neck deformity | 1 0.01 67.03 Neck injury | 1 0.01 67.04 Neck pain | 15 0.15 67.19 Necrotising fasciitis | 2 0.02 67.21 Needle issue | 1 0.01 67.22 Needle track marks | 1 0.01 67.23 Neglect of personal appearance | 1 0.01 67.24 Neonatal aspiration | 3 0.03 67.27 Neonatal disorder | 1 0.01 67.28 Neonatal respiratory distress syndrome | 1 0.01 67.29 Neoplasm | 2 0.02 67.31 Neoplasm malignant | 11 0.11 67.42 Neoplasm progression | 4 0.04 67.46 Nephrogenic systemic fibrosis | 5 0.05 67.51 Nephrolithiasis | 12 0.12 67.63 Nephropathy | 2 0.02 67.65 Nephropathy toxic | 1 0.01 67.66 Nephrosclerosis | 1 0.01 67.67 Nephrotic syndrome | 3 0.03 67.70 Nerve compression | 6 0.06 67.76 Nerve injury | 5 0.05 67.81 Nervous system disorder | 8 0.08 67.89 Nervousness | 6 0.06 67.95 Neuralgia | 6 0.06 68.01 Neuritis | 1 0.01 68.02 Neurodegenerative disorder | 1 0.01 68.03 Neuroendocrine carcinoma of the skin | 1 0.01 68.04 Neuroendocrine tumour | 1 0.01 68.05 Neurofibroma | 2 0.02 68.07 Neurogenic bladder | 4 0.04 68.11 Neurogenic bowel | 1 0.01 68.12 Neuroleptic malignant syndrome | 3 0.03 68.15 Neurological decompensation | 2 0.02 68.17 Neuroma | 1 0.01 68.18 Neuropathy peripheral | 16 0.16 68.34 Neuropsychiatric syndrome | 1 0.01 68.35 Neurotoxicity | 1 0.01 68.36 Neurotransmitter level altered | 1 0.01 68.37 Neutropenia | 15 0.15 68.52 Neutropenic infection | 1 0.01 68.53 Neutropenic sepsis | 2 0.02 68.55 Neutrophil count decreased | 10 0.10 68.65 Neutrophil count increased | 6 0.06 68.71 Neutrophil function disorder | 1 0.01 68.72 Neutrophilia | 4 0.04 68.76 Nicotinic acid deficiency | 1 0.01 68.77 Night sweats | 3 0.03 68.80 Nightmare | 7 0.07 68.87 No adverse event | 3 0.03 68.90 No therapeutic response | 4 0.04 68.94 Nocturia | 2 0.02 68.96 Nodal rhythm | 1 0.01 68.97 Nodule | 4 0.04 69.01 Non-Hodgkin's lymphoma | 1 0.01 69.02 Non-cardiac chest pain | 2 0.02 69.04 Non-small cell lung cancer stage III | 1 0.01 69.05 Norepinephrine increased | 2 0.02 69.07 Nuchal rigidity | 1 0.01 69.08 Nuclear magnetic resonance imaging ab.. | 2 0.02 69.10 Nystagmus | 1 0.01 69.11 ODYNOPHAGIA | 1 0.01 69.12 OEDEMA | 1 0.01 69.13 OEDEMA MOUTH | 1 0.01 69.14 OEDEMA PERIPHERAL | 1 0.01 69.15 OPTIC ATROPHY | 1 0.01 69.16 ORAL HERPES | 1 0.01 69.17 OVERDOSE | 1 0.01 69.18 Obesity | 2 0.02 69.20 Obliterative bronchiolitis | 1 0.01 69.21 Obsessive-compulsive disorder | 1 0.01 69.22 Obsessive-compulsive personality diso.. | 2 0.02 69.24 Occult blood positive | 1 0.01 69.25 Ocular hyperaemia | 2 0.02 69.27 Ocular icterus | 2 0.02 69.29 Odynophagia | 2 0.02 69.31 Oedema | 10 0.10 69.41 Oedema mouth | 1 0.01 69.42 Oedema peripheral | 24 0.24 69.66 Oesophageal carcinoma | 1 0.01 69.67 Oesophageal disorder | 2 0.02 69.69 Oesophageal irritation | 1 0.01 69.70 Oesophageal motility disorder | 1 0.01 69.71 Oesophageal pain | 1 0.01 69.72 Oesophageal stenosis | 1 0.01 69.73 Oesophageal ulcer | 1 0.01 69.74 Oesophagitis | 3 0.03 69.77 Oesophagogastric fundoplasty | 1 0.01 69.78 Off label use | 46 0.46 70.24 Oligohydramnios | 2 0.02 70.26 Onychoclasis | 3 0.03 70.29 Open fracture | 1 0.01 70.30 Open reduction of fracture | 1 0.01 70.31 Optic disc disorder | 1 0.01 70.32 Optic nerve disorder | 1 0.01 70.33 Optic nerve injury | 1 0.01 70.34 Optic neuritis | 3 0.03 70.37 Oral candidiasis | 2 0.02 70.39 Oral cavity fistula | 2 0.02 70.41 Oral discomfort | 1 0.01 70.42 Oral disorder | 2 0.02 70.44 Oral herpes | 4 0.04 70.48 Oral infection | 1 0.01 70.49 Oral mucosal blistering | 1 0.01 70.50 Oral mucosal erythema | 1 0.01 70.51 Oral pain | 3 0.03 70.54 Oral papilloma | 1 0.01 70.55 Organising pneumonia | 1 0.01 70.56 Oropharyngeal discomfort | 2 0.02 70.58 Oropharyngeal pain | 16 0.16 70.74 Oropharyngeal squamous cell carcinoma | 1 0.01 70.75 Orthopnoea | 2 0.02 70.77 Orthostatic hypotension | 3 0.03 70.80 Osteitis | 1 0.01 70.81 Osteoarthritis | 15 0.15 70.96 Osteolysis | 1 0.01 70.97 Osteomyelitis | 13 0.13 71.10 Osteomyelitis chronic | 2 0.02 71.12 Osteomyelitis viral | 1 0.01 71.13 Osteonecrosis | 9 0.09 71.22 Osteonecrosis of jaw | 17 0.17 71.39 Osteopenia | 5 0.05 71.44 Osteoporosis | 9 0.09 71.53 Osteosclerosis | 1 0.01 71.54 Otosclerosis | 1 0.01 71.55 Ovarian cancer | 2 0.02 71.57 Ovarian cancer stage IV | 1 0.01 71.58 Ovarian cyst | 4 0.04 71.62 Ovarian cyst ruptured | 1 0.01 71.63 Ovarian epithelial cancer recurrent | 1 0.01 71.64 Overdose | 23 0.23 71.87 Overweight | 2 0.02 71.89 Oxygen saturation decreased | 5 0.05 71.94 PAIN | 1 0.01 71.95 PAIN IN JAW | 1 0.01 71.96 PANIC ATTACK | 1 0.01 71.97 PCO2 increased | 1 0.01 71.98 PERIPHERAL ISCHAEMIA | 1 0.01 71.99 PHARYNGEAL OEDEMA | 1 0.01 72.00 PLEURAL EFFUSION | 1 0.01 72.01 PNEUMONIA | 1 0.01 72.02 PRURITUS | 1 0.01 72.03 PSEUDOMONAS INFECTION | 1 0.01 72.04 PULMONARY EMBOLISM | 1 0.01 72.05 PULMONARY OEDEMA | 1 0.01 72.06 PUPIL FIXED | 1 0.01 72.07 PYREXIA | 3 0.03 72.10 Pain | 90 0.90 73.00 Pain in extremity | 55 0.55 73.55 Pain in jaw | 6 0.06 73.61 Pain of skin | 1 0.01 73.62 Painful defaecation | 1 0.01 73.63 Painful respiration | 1 0.01 73.64 Palliative care | 1 0.01 73.65 Pallor | 3 0.03 73.68 Palmar-plantar erythrodysaesthesia sy.. | 2 0.02 73.70 Palpitations | 14 0.14 73.84 Pancreatic atrophy | 1 0.01 73.85 Pancreatic carcinoma | 1 0.01 73.86 Pancreatic carcinoma metastatic | 2 0.02 73.88 Pancreatic disorder | 1 0.01 73.89 Pancreatic pseudocyst | 1 0.01 73.90 Pancreatitis | 12 0.12 74.02 Pancreatitis acute | 3 0.03 74.05 Pancreatitis chronic | 1 0.01 74.06 Pancreatitis necrotising | 2 0.02 74.08 Pancytopenia | 9 0.09 74.17 Panic attack | 12 0.12 74.29 Panic disorder | 1 0.01 74.30 Papillary thyroid cancer | 1 0.01 74.31 Papilloma | 2 0.02 74.33 Papule | 2 0.02 74.35 Paraesthesia | 29 0.29 74.64 Paraesthesia oral | 1 0.01 74.65 Paralysis | 4 0.04 74.69 Paranoia | 5 0.05 74.74 Paraparesis | 1 0.01 74.75 Paraphilia | 1 0.01 74.76 Parathyroid tumour | 1 0.01 74.77 Parkinson's disease | 2 0.02 74.79 Paronychia | 3 0.03 74.82 Parotitis | 1 0.01 74.83 Partial seizures | 1 0.01 74.84 Partner stress | 1 0.01 74.85 Patent ductus arteriosus | 1 0.01 74.86 Pathological fracture | 2 0.02 74.88 Pathological gambling | 2 0.02 74.90 Peau d'orange | 2 0.02 74.92 Pelvic adhesions | 1 0.01 74.93 Pelvic cyst | 1 0.01 74.94 Pelvic fracture | 2 0.02 74.96 Pelvic inflammatory disease | 1 0.01 74.97 Pelvic pain | 1 0.01 74.98 Pelvic venous thrombosis | 2 0.02 75.00 Pemphigoid | 1 0.01 75.01 Peptic ulcer | 2 0.02 75.03 Periarthritis | 1 0.01 75.04 Pericardial calcification | 1 0.01 75.05 Pericardial disease | 1 0.01 75.06 Pericardial effusion | 6 0.06 75.12 Pericarditis | 1 0.01 75.13 Perineal injury | 2 0.02 75.15 Periodontal disease | 1 0.01 75.16 Periorbital oedema | 4 0.04 75.20 Peripheral arterial occlusive disease | 4 0.04 75.24 Peripheral artery stenosis | 1 0.01 75.25 Peripheral artery thrombosis | 1 0.01 75.26 Peripheral coldness | 2 0.02 75.28 Peripheral ischaemia | 2 0.02 75.30 Peripheral motor neuropathy | 1 0.01 75.31 Peripheral sensory neuropathy | 1 0.01 75.32 Peripheral vascular disorder | 2 0.02 75.34 Perirectal abscess | 1 0.01 75.35 Peritoneal adhesions | 1 0.01 75.36 Peritoneal haematoma | 1 0.01 75.37 Peritonitis | 3 0.03 75.40 Peroneal nerve palsy | 6 0.06 75.46 Personality change | 5 0.05 75.51 Petechiae | 1 0.01 75.52 Pharyngeal disorder | 2 0.02 75.54 Pharyngeal erythema | 1 0.01 75.55 Pharyngeal oedema | 2 0.02 75.57 Pharyngitis | 6 0.06 75.63 Pharyngitis streptococcal | 2 0.02 75.65 Phlebitis | 1 0.01 75.66 Phobia | 1 0.01 75.67 Photophobia | 2 0.02 75.69 Photosensitivity reaction | 3 0.03 75.72 Physical assault | 2 0.02 75.74 Physical disability | 2 0.02 75.76 Pigmentation buccal | 1 0.01 75.77 Pigmentation disorder | 2 0.02 75.79 Pituitary tumour | 2 0.02 75.81 Pituitary tumour benign | 2 0.02 75.83 Placenta praevia | 1 0.01 75.84 Placental disorder | 1 0.01 75.85 Plantar fasciitis | 1 0.01 75.86 Plasma cell myeloma | 4 0.04 75.90 Plasmacytoma | 1 0.01 75.91 Platelet aggregation decreased | 1 0.01 75.92 Platelet count decreased | 16 0.16 76.08 Platelet count increased | 5 0.05 76.13 Platelet disorder | 1 0.01 76.14 Pleural effusion | 17 0.17 76.31 Pleurisy | 3 0.03 76.34 Pleuritic pain | 2 0.02 76.36 Pleurothotonus | 1 0.01 76.37 Pneumatosis intestinalis | 1 0.01 76.38 Pneumocephalus | 1 0.01 76.39 Pneumocystis jirovecii pneumonia | 4 0.04 76.43 Pneumonia | 43 0.43 76.86 Pneumonia aspiration | 8 0.08 76.94 Pneumonia bacterial | 1 0.01 76.95 Pneumonia cytomegaloviral | 1 0.01 76.96 Pneumonia legionella | 1 0.01 76.97 Pneumonia pneumococcal | 1 0.01 76.98 Pneumonia respiratory syncytial viral | 1 0.01 76.99 Pneumonia staphylococcal | 2 0.02 77.01 Pneumonitis | 2 0.02 77.03 Pneumothorax | 7 0.07 77.10 Pollakiuria | 4 0.04 77.14 Polyarthritis | 2 0.02 77.16 Polydactyly | 1 0.01 77.17 Polyhydramnios | 1 0.01 77.18 Polymorphic light eruption | 1 0.01 77.19 Polyneuropathy | 2 0.02 77.21 Polyp | 2 0.02 77.23 Poor peripheral circulation | 2 0.02 77.25 Poor quality drug administered | 1 0.01 77.26 Poor quality sleep | 7 0.07 77.33 Poor venous access | 5 0.05 77.38 Porencephaly | 1 0.01 77.39 Porphyria | 1 0.01 77.40 Porphyria non-acute | 1 0.01 77.41 Porphyrins urine increased | 1 0.01 77.42 Portal vein thrombosis | 2 0.02 77.44 Portal venous gas | 1 0.01 77.45 Post concussion syndrome | 1 0.01 77.46 Post lumbar puncture syndrome | 1 0.01 77.47 Post procedural complication | 5 0.05 77.52 Post procedural discomfort | 1 0.01 77.53 Post procedural haemorrhage | 1 0.01 77.54 Post transplant lymphoproliferative d.. | 2 0.02 77.56 Post viral fatigue syndrome | 1 0.01 77.57 Post-traumatic neck syndrome | 2 0.02 77.59 Post-traumatic stress disorder | 2 0.02 77.61 Posterior reversible encephalopathy s.. | 3 0.03 77.64 Postoperative adhesion | 1 0.01 77.65 Postoperative respiratory distress | 1 0.01 77.66 Postoperative wound complication | 1 0.01 77.67 Postoperative wound infection | 4 0.04 77.71 Postpartum hypopituitarism | 1 0.01 77.72 Posture abnormal | 4 0.04 77.76 Poverty of thought content | 1 0.01 77.77 Pre-eclampsia | 3 0.03 77.80 Pre-existing condition improved | 2 0.02 77.82 Prealbumin decreased | 1 0.01 77.83 Precancerous cells present | 2 0.02 77.85 Pregnancy | 7 0.07 77.92 Pregnancy on oral contraceptive | 1 0.01 77.93 Pregnancy with contraceptive device | 3 0.03 77.96 Premature baby | 11 0.11 78.07 Premature delivery | 21 0.21 78.28 Premature labour | 10 0.10 78.38 Premature rupture of membranes | 4 0.04 78.42 Premature separation of placenta | 2 0.02 78.44 Prescribed overdose | 4 0.04 78.48 Presyncope | 4 0.04 78.52 Primary progressive multiple sclerosis | 1 0.01 78.53 Primary sequestrum | 2 0.02 78.55 Procalcitonin increased | 1 0.01 78.56 Procedural complication | 3 0.03 78.59 Procedural hypertension | 1 0.01 78.60 Procedural nausea | 1 0.01 78.61 Procedural pain | 4 0.04 78.65 Procedural site reaction | 1 0.01 78.66 Procedural vomiting | 1 0.01 78.67 Proctalgia | 1 0.01 78.68 Proctitis | 1 0.01 78.69 Proctitis ulcerative | 1 0.01 78.70 Product adhesion issue | 1 0.01 78.71 Product contamination | 1 0.01 78.72 Product contamination physical | 1 0.01 78.73 Product counterfeit | 1 0.01 78.74 Product quality issue | 8 0.08 78.82 Product substitution issue | 1 0.01 78.83 Productive cough | 4 0.04 78.87 Progressive multifocal leukoencephalo.. | 4 0.04 78.91 Prostate cancer | 7 0.07 78.98 Prostatic disorder | 1 0.01 78.99 Prostatic specific antigen increased | 2 0.02 79.01 Prostatitis | 1 0.01 79.02 Prostatomegaly | 1 0.01 79.03 Protein total abnormal | 1 0.01 79.04 Proteinuria | 1 0.01 79.05 Proteus infection | 1 0.01 79.06 Prothrombin level increased | 2 0.02 79.08 Prothrombin time prolonged | 1 0.01 79.09 Protrusion tongue | 1 0.01 79.10 Prurigo | 1 0.01 79.11 Pruritus | 33 0.33 79.44 Pruritus generalised | 4 0.04 79.48 Pseudomembranous colitis | 4 0.04 79.52 Pseudomonal bacteraemia | 1 0.01 79.53 Pseudomonal sepsis | 1 0.01 79.54 Pseudomonas infection | 2 0.02 79.56 Pseudophaeochromocytoma | 1 0.01 79.57 Psoas abscess | 1 0.01 79.58 Psoriasis | 15 0.15 79.73 Psoriatic arthropathy | 1 0.01 79.74 Psychiatric decompensation | 1 0.01 79.75 Psychiatric symptom | 3 0.03 79.78 Psychomotor hyperactivity | 2 0.02 79.80 Psychotic behaviour | 3 0.03 79.83 Psychotic disorder | 8 0.08 79.91 Pulmonary arterial hypertension | 2 0.02 79.93 Pulmonary arteriovenous fistula | 1 0.01 79.94 Pulmonary congestion | 4 0.04 79.98 Pulmonary embolism | 33 0.33 80.31 Pulmonary fibrosis | 3 0.03 80.34 Pulmonary function test decreased | 1 0.01 80.35 Pulmonary haemorrhage | 6 0.06 80.41 Pulmonary hypertension | 7 0.07 80.48 Pulmonary hypoplasia | 4 0.04 80.52 Pulmonary mass | 5 0.05 80.57 Pulmonary mycosis | 1 0.01 80.58 Pulmonary oedema | 15 0.15 80.73 Pulmonary thrombosis | 1 0.01 80.74 Pulmonary valve incompetence | 1 0.01 80.75 Pulmonary valve stenosis | 1 0.01 80.76 Pulmonary vascular disorder | 1 0.01 80.77 Pulse absent | 1 0.01 80.78 Pulse pressure increased | 1 0.01 80.79 Pulseless electrical activity | 2 0.02 80.81 Pupillary reflex impaired | 1 0.01 80.82 Purple glove syndrome | 1 0.01 80.83 Purpura | 2 0.02 80.85 Pustular psoriasis | 5 0.05 80.90 Pyelonephritis | 3 0.03 80.93 Pyloric stenosis | 2 0.02 80.95 Pyrexia | 55 0.55 81.50 Quadriparesis | 3 0.03 81.53 Quality of life decreased | 2 0.02 81.55 RASH | 1 0.01 81.56 RASH MACULAR | 1 0.01 81.57 RASH MACULO-PAPULAR | 1 0.01 81.58 RASH PRURITIC | 1 0.01 81.59 RECTAL HAEMORRHAGE | 2 0.02 81.61 RENAL IMPAIRMENT | 1 0.01 81.62 RHABDOMYOLYSIS | 1 0.01 81.63 RIGHT VENTRICULAR FAILURE | 1 0.01 81.64 RIGHT VENTRICULAR HYPERTROPHY | 1 0.01 81.65 Radiation oesophagitis | 1 0.01 81.66 Radiation pneumonitis | 2 0.02 81.68 Radiculopathy | 1 0.01 81.69 Radius fracture | 1 0.01 81.70 Rales | 2 0.02 81.72 Rapid eye movements sleep abnormal | 1 0.01 81.73 Rash | 38 0.38 82.11 Rash erythematous | 5 0.05 82.16 Rash generalised | 8 0.08 82.24 Rash macular | 5 0.05 82.29 Rash maculo-papular | 7 0.07 82.36 Rash papular | 8 0.08 82.44 Rash pruritic | 3 0.03 82.47 Rash pustular | 1 0.01 82.48 Reading disorder | 1 0.01 82.49 Rectal abscess | 1 0.01 82.50 Rectal cancer | 2 0.02 82.52 Rectal cancer stage 0 | 1 0.01 82.53 Rectal discharge | 1 0.01 82.54 Rectal fissure | 2 0.02 82.56 Rectal haemorrhage | 8 0.08 82.64 Rectal ulcer haemorrhage | 1 0.01 82.65 Red blood cell count decreased | 4 0.04 82.69 Red blood cell sedimentation rate inc.. | 3 0.03 82.72 Red cell distribution width increased | 2 0.02 82.74 Reflexes abnormal | 1 0.01 82.75 Refractory cytopenia with unilineage .. | 1 0.01 82.76 Refusal of treatment by patient | 1 0.01 82.77 Refusal of treatment by relative | 1 0.01 82.78 Renal abscess | 1 0.01 82.79 Renal cell carcinoma | 1 0.01 82.80 Renal cyst | 4 0.04 82.84 Renal cyst haemorrhage | 1 0.01 82.85 Renal disorder | 13 0.13 82.98 Renal dysplasia | 2 0.02 83.00 Renal failure | 20 0.20 83.20 Renal failure acute | 30 0.30 83.50 Renal failure chronic | 6 0.06 83.56 Renal haemorrhage | 1 0.01 83.57 Renal impairment | 16 0.16 83.73 Renal injury | 7 0.07 83.80 Renal pain | 2 0.02 83.82 Renal tubular atrophy | 1 0.01 83.83 Renal tubular necrosis | 2 0.02 83.85 Respiratory acidosis | 2 0.02 83.87 Respiratory arrest | 7 0.07 83.94 Respiratory disorder | 5 0.05 83.99 Respiratory distress | 8 0.08 84.07 Respiratory failure | 25 0.25 84.32 Respiratory syncytial virus infection | 1 0.01 84.33 Respiratory tract congestion | 2 0.02 84.35 Respiratory tract infection | 5 0.05 84.40 Respiratory tract infection viral | 1 0.01 84.41 Respiratory tract inflammation | 1 0.01 84.42 Restless legs syndrome | 5 0.05 84.47 Restlessness | 9 0.09 84.56 Restrictive cardiomyopathy | 1 0.01 84.57 Retained placenta or membranes | 2 0.02 84.59 Retained products of conception | 1 0.01 84.60 Retinal artery occlusion | 1 0.01 84.61 Retinal artery thrombosis | 1 0.01 84.62 Retinal degeneration | 1 0.01 84.63 Retinal detachment | 4 0.04 84.67 Retrograde ejaculation | 1 0.01 84.68 Retroplacental haematoma | 2 0.02 84.70 Rhabdomyolysis | 8 0.08 84.78 Rheumatic disorder | 1 0.01 84.79 Rheumatoid arthritis | 9 0.09 84.88 Rheumatoid factor increased | 1 0.01 84.89 Rheumatoid factor positive | 1 0.01 84.90 Rheumatoid nodule | 3 0.03 84.93 Rhinitis | 2 0.02 84.95 Rhinitis allergic | 2 0.02 84.97 Rhinorrhoea | 6 0.06 85.03 Rib fracture | 6 0.06 85.09 Right ventricular dysfunction | 1 0.01 85.10 Right ventricular failure | 1 0.01 85.11 Road traffic accident | 13 0.13 85.24 Rotator cuff syndrome | 13 0.13 85.37 Ruptured ectopic pregnancy | 1 0.01 85.38 SEDATION | 1 0.01 85.39 SEROTONIN SYNDROME | 1 0.01 85.40 SIMPLE PARTIAL SEIZURES | 2 0.02 85.42 SKIN OEDEMA | 1 0.01 85.43 SOMNOLENCE | 2 0.02 85.45 SPLENOMEGALY | 1 0.01 85.46 STAPHYLOCOCCAL SEPSIS | 1 0.01 85.47 STEATORRHOEA | 1 0.01 85.48 SUDDEN DEATH | 2 0.02 85.50 SUICIDAL IDEATION | 3 0.03 85.53 SWOLLEN TONGUE | 1 0.01 85.54 SYNCOPE | 1 0.01 85.55 Salivary hypersecretion | 2 0.02 85.57 Sarcoma | 1 0.01 85.58 Scab | 2 0.02 85.60 Scar | 10 0.10 85.70 Schizophrenia | 3 0.03 85.73 Schizophrenia, undifferentiated type | 1 0.01 85.74 Schizophreniform disorder | 1 0.01 85.75 Sciatic nerve injury | 1 0.01 85.76 Sciatica | 5 0.05 85.81 Scleritis | 1 0.01 85.82 Scleroderma | 2 0.02 85.84 Scoliosis | 3 0.03 85.87 Scratch | 2 0.02 85.89 Screaming | 1 0.01 85.90 Seasonal allergy | 2 0.02 85.92 Sebaceous hyperplasia | 1 0.01 85.93 Seborrhoeic dermatitis | 2 0.02 85.95 Seborrhoeic keratosis | 1 0.01 85.96 Second primary malignancy | 2 0.02 85.98 Secondary progressive multiple sclero.. | 1 0.01 85.99 Sedation | 4 0.04 86.03 Selective abortion | 2 0.02 86.05 Self esteem decreased | 2 0.02 86.07 Self injurious behaviour | 3 0.03 86.10 Sensation of foreign body | 1 0.01 86.11 Sensation of heaviness | 1 0.01 86.12 Sensation of pressure | 1 0.01 86.13 Sensory disturbance | 1 0.01 86.14 Sepsis | 22 0.22 86.36 Sepsis pasteurella | 1 0.01 86.37 Septic shock | 7 0.07 86.44 Serum ferritin decreased | 1 0.01 86.45 Serum ferritin increased | 2 0.02 86.47 Serum sickness | 1 0.01 86.48 Serum sickness-like reaction | 3 0.03 86.51 Sexual dysfunction | 3 0.03 86.54 Shock | 3 0.03 86.57 Shock haemorrhagic | 2 0.02 86.59 Sick sinus syndrome | 1 0.01 86.60 Silent myocardial infarction | 1 0.01 86.61 Sinoatrial block | 1 0.01 86.62 Sinus arrest | 1 0.01 86.63 Sinus bradycardia | 1 0.01 86.64 Sinus congestion | 1 0.01 86.65 Sinus disorder | 3 0.03 86.68 Sinus headache | 2 0.02 86.70 Sinus tachycardia | 6 0.06 86.76 Sinusitis | 17 0.17 86.93 Sjogren's syndrome | 2 0.02 86.95 Skeletal injury | 3 0.03 86.98 Skin atrophy | 3 0.03 87.01 Skin burning sensation | 5 0.05 87.06 Skin cancer | 3 0.03 87.09 Skin discolouration | 6 0.06 87.15 Skin disorder | 6 0.06 87.21 Skin erosion | 1 0.01 87.22 Skin exfoliation | 7 0.07 87.29 Skin fibrosis | 3 0.03 87.32 Skin fissures | 3 0.03 87.35 Skin haemorrhage | 5 0.05 87.40 Skin hyperpigmentation | 2 0.02 87.42 Skin hypertrophy | 5 0.05 87.47 Skin hypopigmentation | 1 0.01 87.48 Skin induration | 3 0.03 87.51 Skin infection | 2 0.02 87.53 Skin irritation | 2 0.02 87.55 Skin lesion | 12 0.12 87.67 Skin necrosis | 4 0.04 87.71 Skin odour abnormal | 1 0.01 87.72 Skin papilloma | 1 0.01 87.73 Skin plaque | 3 0.03 87.76 Skin reaction | 3 0.03 87.79 Skin swelling | 3 0.03 87.82 Skin tightness | 3 0.03 87.85 Skin toxicity | 2 0.02 87.87 Skin ulcer | 3 0.03 87.90 Skin wrinkling | 1 0.01 87.91 Skull fracture | 3 0.03 87.94 Sleep apnoea syndrome | 5 0.05 87.99 Sleep disorder | 9 0.09 88.08 Sleep disorder due to a general medic.. | 1 0.01 88.09 Sluggishness | 1 0.01 88.10 Small cell lung cancer | 1 0.01 88.11 Small for dates baby | 2 0.02 88.13 Small intestinal obstruction | 5 0.05 88.18 Small intestinal perforation | 1 0.01 88.19 Small intestine ulcer | 1 0.01 88.20 Social avoidant behaviour | 1 0.01 88.21 Social problem | 1 0.01 88.22 Soft tissue inflammation | 1 0.01 88.23 Soft tissue injury | 1 0.01 88.24 Somatic delusion | 1 0.01 88.25 Somnolence | 34 0.34 88.59 Speech disorder | 13 0.13 88.72 Spina bifida | 1 0.01 88.73 Spinal column injury | 2 0.02 88.75 Spinal column stenosis | 7 0.07 88.82 Spinal compression fracture | 4 0.04 88.86 Spinal cord injury cervical | 1 0.01 88.87 Spinal decompression | 1 0.01 88.88 Spinal disorder | 3 0.03 88.91 Spinal fracture | 5 0.05 88.96 Spinal fusion surgery | 1 0.01 88.97 Spinal laminectomy | 1 0.01 88.98 Spinal osteoarthritis | 2 0.02 89.00 Spinal pain | 1 0.01 89.01 Splenic granuloma | 1 0.01 89.02 Splenic infarction | 1 0.01 89.03 Splenic vein thrombosis | 1 0.01 89.04 Splenomegaly | 1 0.01 89.05 Spondylitic myelopathy | 1 0.01 89.06 Spondylitis | 1 0.01 89.07 Spondylolisthesis | 1 0.01 89.08 Squamous cell carcinoma | 2 0.02 89.10 Squamous cell carcinoma of head and n.. | 2 0.02 89.12 Squamous cell carcinoma of skin | 2 0.02 89.14 Squamous cell carcinoma of the oral c.. | 2 0.02 89.16 Staphylococcal abscess | 2 0.02 89.18 Staphylococcal bacteraemia | 2 0.02 89.20 Staphylococcal infection | 9 0.09 89.29 Staphylococcal sepsis | 2 0.02 89.31 Staphylococcus test positive | 1 0.01 89.32 Status epilepticus | 1 0.01 89.33 Steatorrhoea | 1 0.01 89.34 Stevens-Johnson syndrome | 21 0.21 89.55 Stillbirth | 5 0.05 89.60 Stomatitis | 8 0.08 89.68 Strabismus | 1 0.01 89.69 Stress | 17 0.17 89.86 Stress fracture | 1 0.01 89.87 Stupor | 2 0.02 89.89 Subarachnoid haemorrhage | 8 0.08 89.97 Subarachnoid haemorrhage neonatal | 1 0.01 89.98 Subclavian vein thrombosis | 2 0.02 90.00 Subcutaneous abscess | 2 0.02 90.02 Subdural haemorrhage | 1 0.01 90.03 Subileus | 1 0.01 90.04 Substance abuse | 1 0.01 90.05 Substance-induced psychotic disorder | 1 0.01 90.06 Sudden death | 5 0.05 90.11 Sudden infant death syndrome | 1 0.01 90.12 Suicidal behaviour | 1 0.01 90.13 Suicidal ideation | 32 0.32 90.45 Suicide attempt | 15 0.15 90.60 Superior sagittal sinus thrombosis | 2 0.02 90.62 Supraventricular tachycardia | 3 0.03 90.65 Surgery | 7 0.07 90.72 Suspiciousness | 1 0.01 90.73 Suture rupture | 1 0.01 90.74 Swelling | 14 0.14 90.88 Swelling face | 4 0.04 90.92 Swollen tongue | 2 0.02 90.94 Syncope | 11 0.11 91.05 Synovial cyst | 1 0.01 91.06 Synovitis | 2 0.02 91.08 Systemic inflammatory response syndrome | 2 0.02 91.10 Systemic lupus erythematosus | 2 0.02 91.12 TENDERNESS | 1 0.01 91.13 TIC | 1 0.01 91.14 TINNITUS | 1 0.01 91.15 TOOTH FRACTURE | 1 0.01 91.16 TOXICITY TO VARIOUS AGENTS | 2 0.02 91.18 TREMOR | 1 0.01 91.19 Tachycardia | 24 0.24 91.43 Tachyphrenia | 1 0.01 91.44 Tachypnoea | 3 0.03 91.47 Talipes | 1 0.01 91.48 Tardive dyskinesia | 4 0.04 91.52 Tearfulness | 4 0.04 91.56 Temperature intolerance | 4 0.04 91.60 Tenderness | 1 0.01 91.61 Tendinous contracture | 1 0.01 91.62 Tendon disorder | 7 0.07 91.69 Tendon injury | 1 0.01 91.70 Tendon rupture | 13 0.13 91.83 Tendonitis | 13 0.13 91.96 Tenosynovitis | 2 0.02 91.98 Tenosynovitis stenosans | 2 0.02 92.00 Tension | 3 0.03 92.03 Terminal state | 2 0.02 92.05 Tetany | 1 0.01 92.06 Thalamic infarction | 1 0.01 92.07 Theft | 1 0.01 92.08 Therapeutic response decreased | 3 0.03 92.11 Therapeutic response unexpected | 4 0.04 92.15 Therapy cessation | 2 0.02 92.17 Thermal burn | 1 0.01 92.18 Thermohypoaesthesia | 1 0.01 92.19 Thinking abnormal | 5 0.05 92.24 Thirst | 2 0.02 92.26 Thoracic vertebral fracture | 1 0.01 92.27 Thought blocking | 1 0.01 92.28 Throat irritation | 3 0.03 92.31 Throat tightness | 2 0.02 92.33 Thromboangiitis obliterans | 1 0.01 92.34 Thrombocytopenia | 21 0.21 92.55 Thrombophlebitis | 4 0.04 92.59 Thrombophlebitis superficial | 1 0.01 92.60 Thrombosis | 18 0.18 92.78 Thrombotic microangiopathy | 3 0.03 92.81 Thrombotic thrombocytopenic purpura | 1 0.01 92.82 Thymus disorder | 1 0.01 92.83 Thyroid atrophy | 1 0.01 92.84 Thyroid cancer | 3 0.03 92.87 Thyroid disorder | 4 0.04 92.91 Thyroid function test abnormal | 1 0.01 92.92 Thyroid mass | 2 0.02 92.94 Thyroid neoplasm | 3 0.03 92.97 Thyroiditis | 1 0.01 92.98 Thyroiditis fibrous chronic | 1 0.01 92.99 Thyroxine free increased | 1 0.01 93.00 Tibia fracture | 1 0.01 93.01 Tic | 2 0.02 93.03 Tinea pedis | 2 0.02 93.05 Tinnitus | 1 0.01 93.06 Tongue biting | 2 0.02 93.08 Tongue discolouration | 2 0.02 93.10 Tongue dysplasia | 1 0.01 93.11 Tonic convulsion | 1 0.01 93.12 Tonsillar disorder | 1 0.01 93.13 Tonsillitis | 1 0.01 93.14 Tooth abscess | 3 0.03 93.17 Tooth avulsion | 1 0.01 93.18 Tooth discolouration | 1 0.01 93.19 Tooth disorder | 4 0.04 93.23 Tooth extraction | 6 0.06 93.29 Tooth fracture | 3 0.03 93.32 Tooth infection | 7 0.07 93.39 Tooth injury | 1 0.01 93.40 Toothache | 3 0.03 93.43 Torsade de pointes | 4 0.04 93.47 Total lung capacity decreased | 1 0.01 93.48 Toxic epidermal necrolysis | 3 0.03 93.51 Toxic neuropathy | 1 0.01 93.52 Toxic skin eruption | 1 0.01 93.53 Toxicity to various agents | 23 0.23 93.76 Tracheal haemorrhage | 1 0.01 93.77 Tracheo-oesophageal fistula | 1 0.01 93.78 Transaminases abnormal | 1 0.01 93.79 Transaminases increased | 2 0.02 93.81 Transfusion reaction | 2 0.02 93.83 Transient ischaemic attack | 10 0.10 93.93 Transplant rejection | 1 0.01 93.94 Transverse sinus thrombosis | 1 0.01 93.95 Traumatic lung injury | 2 0.02 93.97 Treatment noncompliance | 2 0.02 93.99 Tremor | 40 0.40 94.39 Tremor neonatal | 1 0.01 94.40 Trichorrhexis | 1 0.01 94.41 Tricuspid valve incompetence | 3 0.03 94.44 Trigeminal neuralgia | 2 0.02 94.46 Trigger finger | 2 0.02 94.48 Trimethylaminuria | 1 0.01 94.49 Trismus | 2 0.02 94.51 Troponin T increased | 1 0.01 94.52 Troponin increased | 2 0.02 94.54 Tuberculosis | 2 0.02 94.56 Tubulointerstitial nephritis | 4 0.04 94.60 Tumour flare | 1 0.01 94.61 Tumour invasion | 1 0.01 94.62 Tumour lysis syndrome | 1 0.01 94.63 Tumour marker increased | 1 0.01 94.64 Tunnel vision | 1 0.01 94.65 Turner's syndrome | 1 0.01 94.66 Tympanic membrane perforation | 1 0.01 94.67 Type 1 diabetes mellitus | 1 0.01 94.68 Type 2 diabetes mellitus | 3 0.03 94.71 Type IV hypersensitivity reaction | 1 0.01 94.72 UNRESPONSIVE TO STIMULI | 1 0.01 94.73 URINARY RETENTION | 1 0.01 94.74 Ulcer | 3 0.03 94.77 Ulcer haemorrhage | 1 0.01 94.78 Ultrasound antenatal screen abnormal | 1 0.01 94.79 Umbilical cord around neck | 1 0.01 94.80 Underdose | 2 0.02 94.82 Unevaluable event | 8 0.08 94.90 Unintended pregnancy | 2 0.02 94.92 Unresponsive to stimuli | 5 0.05 94.97 Upper gastrointestinal haemorrhage | 1 0.01 94.98 Upper limb fracture | 5 0.05 95.03 Upper motor neurone lesion | 1 0.01 95.04 Upper respiratory tract congestion | 2 0.02 95.06 Upper respiratory tract infection | 10 0.10 95.16 Upper respiratory tract inflammation | 3 0.03 95.19 Upper-airway cough syndrome | 1 0.01 95.20 Ureteric cancer metastatic | 1 0.01 95.21 Ureteric obstruction | 2 0.02 95.23 Urethral cancer | 1 0.01 95.24 Urethral caruncle | 1 0.01 95.25 Urethral stenosis | 1 0.01 95.26 Urge incontinence | 1 0.01 95.27 Urinary incontinence | 12 0.12 95.39 Urinary retention | 5 0.05 95.44 Urinary tract disorder | 1 0.01 95.45 Urinary tract infection | 36 0.36 95.81 Urinary tract infection enterococcal | 2 0.02 95.83 Urinary tract infection pseudomonal | 2 0.02 95.85 Urine analysis abnormal | 1 0.01 95.86 Urine output decreased | 1 0.01 95.87 Urine potassium increased | 1 0.01 95.88 Urogenital atrophy | 1 0.01 95.89 Urosepsis | 1 0.01 95.90 Urticaria | 12 0.12 96.02 Uterine cancer | 1 0.01 96.03 Uterine contractions during pregnancy | 1 0.01 96.04 Uterine haemorrhage | 2 0.02 96.06 Uterine leiomyoma | 2 0.02 96.08 Uterine polyp | 1 0.01 96.09 Uterine prolapse | 1 0.01 96.10 Uterine rupture | 1 0.01 96.11 Uveitis | 2 0.02 96.13 VAGINAL ABSCESS | 1 0.01 96.14 VARICOSE VEIN | 1 0.01 96.15 VENOOCCLUSIVE LIVER DISEASE | 1 0.01 96.16 VIIth nerve paralysis | 1 0.01 96.17 VISUAL ACUITY REDUCED | 1 0.01 96.18 VISUAL FIELD DEFECT | 1 0.01 96.19 VIth nerve paralysis | 1 0.01 96.20 VOMITING | 1 0.01 96.21 Vaccination failure | 1 0.01 96.22 Vaginal abscess | 1 0.01 96.23 Vaginal cancer | 1 0.01 96.24 Vaginal discharge | 1 0.01 96.25 Vaginal haemorrhage | 5 0.05 96.30 Vaginal infection | 2 0.02 96.32 Vagus nerve disorder | 1 0.01 96.33 Vanishing bile duct syndrome | 1 0.01 96.34 Varicose vein | 3 0.03 96.37 Varicose vein ruptured | 1 0.01 96.38 Vascular anomaly | 2 0.02 96.40 Vascular calcification | 1 0.01 96.41 Vascular graft | 1 0.01 96.42 Vascular graft complication | 1 0.01 96.43 Vascular headache | 1 0.01 96.44 Vascular occlusion | 1 0.01 96.45 Vasculitis | 2 0.02 96.47 Vasculitis cerebral | 1 0.01 96.48 Vasodilatation | 1 0.01 96.49 Vein disorder | 2 0.02 96.51 Vena cava thrombosis | 1 0.01 96.52 Venoocclusive liver disease | 2 0.02 96.54 Venous insufficiency | 1 0.01 96.55 Venous pressure jugular increased | 1 0.01 96.56 Venous thrombosis | 1 0.01 96.57 Ventricular arrhythmia | 1 0.01 96.58 Ventricular dysfunction | 1 0.01 96.59 Ventricular extrasystoles | 4 0.04 96.63 Ventricular fibrillation | 3 0.03 96.66 Ventricular hypokinesia | 1 0.01 96.67 Ventricular hypoplasia | 1 0.01 96.68 Ventricular septal defect | 1 0.01 96.69 Ventricular tachycardia | 4 0.04 96.73 Vertigo | 7 0.07 96.80 Vertigo positional | 1 0.01 96.81 Vesicoureteric reflux | 1 0.01 96.82 Victim of crime | 1 0.01 96.83 Violence-related symptom | 1 0.01 96.84 Viral infection | 5 0.05 96.89 Viral load increased | 2 0.02 96.91 Viral tonsillitis | 1 0.01 96.92 Vision blurred | 17 0.17 97.09 Visual acuity reduced | 13 0.13 97.22 Visual impairment | 18 0.18 97.40 Vitamin D decreased | 6 0.06 97.46 Vitamin D deficiency | 2 0.02 97.48 Vocal cord thickening | 1 0.01 97.49 Vomiting | 62 0.62 98.11 Vomiting neonatal | 1 0.01 98.12 Vulval disorder | 1 0.01 98.13 Vulvovaginal burning sensation | 1 0.01 98.14 Vulvovaginal dryness | 1 0.01 98.15 Vulvovaginal human papilloma virus in.. | 1 0.01 98.16 Vulvovaginal pruritus | 1 0.01 98.17 WEIGHT INCREASED | 1 0.01 98.18 WHITE BLOOD CELL COUNT INCREASED | 2 0.02 98.20 Waldenstrom's macroglobulinaemia | 1 0.01 98.21 Walking aid user | 2 0.02 98.23 Weaning failure | 1 0.01 98.24 Weight decrease neonatal | 1 0.01 98.25 Weight decreased | 49 0.49 98.74 Weight fluctuation | 3 0.03 98.77 Weight gain poor | 1 0.01 98.78 Weight increased | 48 0.48 99.26 Wheelchair user | 2 0.02 99.28 Wheezing | 9 0.09 99.37 White blood cell count decreased | 11 0.11 99.48 White blood cell count increased | 19 0.19 99.67 White blood cell disorder | 1 0.01 99.68 White blood cells urine positive | 1 0.01 99.69 Withdrawal syndrome | 4 0.04 99.73 Wound | 4 0.04 99.77 Wound abscess | 1 0.01 99.78 Wound closure | 1 0.01 99.79 Wound decomposition | 1 0.01 99.80 Wound dehiscence | 1 0.01 99.81 Wound evisceration | 1 0.01 99.82 Wound haemorrhage | 1 0.01 99.83 Wound infection | 3 0.03 99.86 Wound infection staphylococcal | 1 0.01 99.87 Wrist fracture | 3 0.03 99.90 Wrong technique in drug usage process | 7 0.07 99.97 X-ray abnormal | 1 0.01 99.98 Xerosis | 1 0.01 99.99 Yawning | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 7 Apr 2017